The To-Don’t List

Article Type
Changed
Display Headline
The To-Don’t List

Last month, I wrote about the attributes of hospitalist practices that I associate with success. This month, I’ll do the opposite. That is, I’ll write about strategies your practice could, or even should, do without. Of course, all of these things are open to debate, and some thoughtful people might (and in my experience, probably will) arrive at different conclusions.

So I offer my list as food for thought, and if your practice relies on some of these strategies, you shouldn’t feel threatened by my opinion. But you might want to think about whether they’ve been made part of your practice by design, or if things just evolved this way without careful consideration of alternatives. I’ve listed them in no particular order.

Fixed-duration day shifts. My sense is that the majority of practices have a day shift with a predetermined start and end. That is, the hospitalist is expected to arrive and depart at the same time each day.

This seems to make a lot of sense, but it ignores the dramatic variations in workload a practice will have. For example, a practice that is appropriately staffed with four daytime hospitalists, and schedules each of them to work a 12-hour shift, provides 48 hours of daytime hospitalist manpower each day. But that will turn out to be precisely the right level of staffing only a few days a year. On all other days, daytime staffing will be optimal with a different number of hours. So it would make sense for the doctors to work more or less on those days.

Paying a new hospitalist a lower salary that increases automatically every few years isn’t really a raise earned by the doctor’s improved financial performance. Usually it’s just a system of withholding money that could be available for compensation for the doctor’s first few years in the practice. This lower starting salary might adversely impact recruiting.

Telling doctors that their shift always starts at the same time has significant lifestyle advantages. But it can inhibit the doctors who would be happy to start earlier to address more discharges early in the day and potentially go home earlier. So, just like most other doctors at your hospital have, why not let the doctors have significant latitude in when they start and stop working each day? In most cases, it might be necessary to have a time by which every doctor must be available to respond to pages (and one who must be on-site before the night doctor leaves), but they should feel free to actually arrive and start working when they choose. Most will make good choices and will likely feel a little more empowered and happy with their work.

And, at the end of the day, it might be reasonable to allow some of the day-shift doctors to leave when their work is done, and allow the others to stay to handle admissions until the night shift takes over. Those who leave early might still be required to respond to pages until a specified time.

Shifts that don’t involve rounding on “continuity” patients, such as night and evening (“swing”) shifts, usually should be arranged with predetermined start. I wrote in more detail on this topic in January 2007 and October 2010.

Contractual vacation provisions. Hospitalists should have significant amounts of time off. We work a lot of evenings, nights, and weekends, and we must have liberal amounts of time away from work. But for many practices, there is no advantage in classifying this time as vacation (or CME, etc.) time. In most cases, it makes the most sense to simply specify how much work (e.g. number of shifts) a doctor is to do each year and not specify a number of days or hours of vacation time. For more detail, read “The Vacation Conundrum” from March 2007.

 

 

If your practice has a vacation system that works well, then stick with it. But if you or your administrators are going nuts trying to categorize nonworking days between vacation and days the doctor simply wasn’t scheduled, then it might be best to stop trying. Just settle on the number of shifts (or some other metric) that a doctor is to work each year.

Tenure-based salary increases. It makes a lot of sense to pay doctors in most specialties an increasing salary based on his or her tenure with the practice. As they build a patient population and a referral stream, they generate more revenue and should benefit accordingly. But a new hospitalist who joins an existing group almost never has to build the referrals. In most cases, the group hired the doctor because the referrals are already coming and the practice needs more help, or the new doctor is replacing a departing one. So paying a new hospitalist a lower salary that increases automatically every few years isn’t really a raise earned by the doctor’s improved financial performance. Usually it’s just a system of withholding money that could be available for compensation for the doctor’s first few years in the practice. This lower starting salary might adversely impact recruiting. For more, see “Compensation Conundrum” from December 2009.

Poor roles for nonphysician providers (NPPs). I’ve worked with a lot of practices that have NPs and PAs (and, in some cases, RNs) who are doing what amounts to clerical work. They’re faxing discharge summaries, making calls to schedule patient appointments, dividing up the overnight admissions for the day rounders, etc.

Don’t make this mistake. Hire a secretary for that sort of work. And be sure that the roles occupied by trained clinicians (PAs, NPs, RNs, etc.) are professionally satisfying and will position them to make an effective contribution to the practice.

For more on this topic, see “The 411 on NPPs” from September 2008 and “Role Refinement” from September 2009; the latter features the perspective of Ryan Genzink, a thoughtful PA-C from Michigan.

Blinded performance reporting. First, make sure your practice provides regular, meaningful reports on each doctor’s performance and the group as a whole. This usually takes the form of a dashboard or report card. In my experience, too few practices do this. Make sure your group isn’t in that category.

Groups that do provide performance data often allow each doctor to see only his or her data. If data about other individuals in the group are provided, the names have often been removed. With exception of certain human resources issues (e.g. counseling a doctor to prevent termination), I think all performance data in the group should be shared by name with the whole group. In most practices, everyone should know by name which doctors are the high and low producers, each doctor’s compensation, and CPT coding practices (e.g. the portion of discharges coded at the high level).

When clinical performance can be attributed to individual providers, report those metrics openly, too. This usually creates greater cohesion within the group and helps foster a mentality of practice ownership. TH

Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants a national hospitalist practice management consulting firm (www.nelsonflores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program.” This column represents his views and is not intended to reflect an official position of SHM.

Issue
The Hospitalist - 2011(04)
Publications
Sections

Last month, I wrote about the attributes of hospitalist practices that I associate with success. This month, I’ll do the opposite. That is, I’ll write about strategies your practice could, or even should, do without. Of course, all of these things are open to debate, and some thoughtful people might (and in my experience, probably will) arrive at different conclusions.

So I offer my list as food for thought, and if your practice relies on some of these strategies, you shouldn’t feel threatened by my opinion. But you might want to think about whether they’ve been made part of your practice by design, or if things just evolved this way without careful consideration of alternatives. I’ve listed them in no particular order.

Fixed-duration day shifts. My sense is that the majority of practices have a day shift with a predetermined start and end. That is, the hospitalist is expected to arrive and depart at the same time each day.

This seems to make a lot of sense, but it ignores the dramatic variations in workload a practice will have. For example, a practice that is appropriately staffed with four daytime hospitalists, and schedules each of them to work a 12-hour shift, provides 48 hours of daytime hospitalist manpower each day. But that will turn out to be precisely the right level of staffing only a few days a year. On all other days, daytime staffing will be optimal with a different number of hours. So it would make sense for the doctors to work more or less on those days.

Paying a new hospitalist a lower salary that increases automatically every few years isn’t really a raise earned by the doctor’s improved financial performance. Usually it’s just a system of withholding money that could be available for compensation for the doctor’s first few years in the practice. This lower starting salary might adversely impact recruiting.

Telling doctors that their shift always starts at the same time has significant lifestyle advantages. But it can inhibit the doctors who would be happy to start earlier to address more discharges early in the day and potentially go home earlier. So, just like most other doctors at your hospital have, why not let the doctors have significant latitude in when they start and stop working each day? In most cases, it might be necessary to have a time by which every doctor must be available to respond to pages (and one who must be on-site before the night doctor leaves), but they should feel free to actually arrive and start working when they choose. Most will make good choices and will likely feel a little more empowered and happy with their work.

And, at the end of the day, it might be reasonable to allow some of the day-shift doctors to leave when their work is done, and allow the others to stay to handle admissions until the night shift takes over. Those who leave early might still be required to respond to pages until a specified time.

Shifts that don’t involve rounding on “continuity” patients, such as night and evening (“swing”) shifts, usually should be arranged with predetermined start. I wrote in more detail on this topic in January 2007 and October 2010.

Contractual vacation provisions. Hospitalists should have significant amounts of time off. We work a lot of evenings, nights, and weekends, and we must have liberal amounts of time away from work. But for many practices, there is no advantage in classifying this time as vacation (or CME, etc.) time. In most cases, it makes the most sense to simply specify how much work (e.g. number of shifts) a doctor is to do each year and not specify a number of days or hours of vacation time. For more detail, read “The Vacation Conundrum” from March 2007.

 

 

If your practice has a vacation system that works well, then stick with it. But if you or your administrators are going nuts trying to categorize nonworking days between vacation and days the doctor simply wasn’t scheduled, then it might be best to stop trying. Just settle on the number of shifts (or some other metric) that a doctor is to work each year.

Tenure-based salary increases. It makes a lot of sense to pay doctors in most specialties an increasing salary based on his or her tenure with the practice. As they build a patient population and a referral stream, they generate more revenue and should benefit accordingly. But a new hospitalist who joins an existing group almost never has to build the referrals. In most cases, the group hired the doctor because the referrals are already coming and the practice needs more help, or the new doctor is replacing a departing one. So paying a new hospitalist a lower salary that increases automatically every few years isn’t really a raise earned by the doctor’s improved financial performance. Usually it’s just a system of withholding money that could be available for compensation for the doctor’s first few years in the practice. This lower starting salary might adversely impact recruiting. For more, see “Compensation Conundrum” from December 2009.

Poor roles for nonphysician providers (NPPs). I’ve worked with a lot of practices that have NPs and PAs (and, in some cases, RNs) who are doing what amounts to clerical work. They’re faxing discharge summaries, making calls to schedule patient appointments, dividing up the overnight admissions for the day rounders, etc.

Don’t make this mistake. Hire a secretary for that sort of work. And be sure that the roles occupied by trained clinicians (PAs, NPs, RNs, etc.) are professionally satisfying and will position them to make an effective contribution to the practice.

For more on this topic, see “The 411 on NPPs” from September 2008 and “Role Refinement” from September 2009; the latter features the perspective of Ryan Genzink, a thoughtful PA-C from Michigan.

Blinded performance reporting. First, make sure your practice provides regular, meaningful reports on each doctor’s performance and the group as a whole. This usually takes the form of a dashboard or report card. In my experience, too few practices do this. Make sure your group isn’t in that category.

Groups that do provide performance data often allow each doctor to see only his or her data. If data about other individuals in the group are provided, the names have often been removed. With exception of certain human resources issues (e.g. counseling a doctor to prevent termination), I think all performance data in the group should be shared by name with the whole group. In most practices, everyone should know by name which doctors are the high and low producers, each doctor’s compensation, and CPT coding practices (e.g. the portion of discharges coded at the high level).

When clinical performance can be attributed to individual providers, report those metrics openly, too. This usually creates greater cohesion within the group and helps foster a mentality of practice ownership. TH

Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants a national hospitalist practice management consulting firm (www.nelsonflores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program.” This column represents his views and is not intended to reflect an official position of SHM.

Last month, I wrote about the attributes of hospitalist practices that I associate with success. This month, I’ll do the opposite. That is, I’ll write about strategies your practice could, or even should, do without. Of course, all of these things are open to debate, and some thoughtful people might (and in my experience, probably will) arrive at different conclusions.

So I offer my list as food for thought, and if your practice relies on some of these strategies, you shouldn’t feel threatened by my opinion. But you might want to think about whether they’ve been made part of your practice by design, or if things just evolved this way without careful consideration of alternatives. I’ve listed them in no particular order.

Fixed-duration day shifts. My sense is that the majority of practices have a day shift with a predetermined start and end. That is, the hospitalist is expected to arrive and depart at the same time each day.

This seems to make a lot of sense, but it ignores the dramatic variations in workload a practice will have. For example, a practice that is appropriately staffed with four daytime hospitalists, and schedules each of them to work a 12-hour shift, provides 48 hours of daytime hospitalist manpower each day. But that will turn out to be precisely the right level of staffing only a few days a year. On all other days, daytime staffing will be optimal with a different number of hours. So it would make sense for the doctors to work more or less on those days.

Paying a new hospitalist a lower salary that increases automatically every few years isn’t really a raise earned by the doctor’s improved financial performance. Usually it’s just a system of withholding money that could be available for compensation for the doctor’s first few years in the practice. This lower starting salary might adversely impact recruiting.

Telling doctors that their shift always starts at the same time has significant lifestyle advantages. But it can inhibit the doctors who would be happy to start earlier to address more discharges early in the day and potentially go home earlier. So, just like most other doctors at your hospital have, why not let the doctors have significant latitude in when they start and stop working each day? In most cases, it might be necessary to have a time by which every doctor must be available to respond to pages (and one who must be on-site before the night doctor leaves), but they should feel free to actually arrive and start working when they choose. Most will make good choices and will likely feel a little more empowered and happy with their work.

And, at the end of the day, it might be reasonable to allow some of the day-shift doctors to leave when their work is done, and allow the others to stay to handle admissions until the night shift takes over. Those who leave early might still be required to respond to pages until a specified time.

Shifts that don’t involve rounding on “continuity” patients, such as night and evening (“swing”) shifts, usually should be arranged with predetermined start. I wrote in more detail on this topic in January 2007 and October 2010.

Contractual vacation provisions. Hospitalists should have significant amounts of time off. We work a lot of evenings, nights, and weekends, and we must have liberal amounts of time away from work. But for many practices, there is no advantage in classifying this time as vacation (or CME, etc.) time. In most cases, it makes the most sense to simply specify how much work (e.g. number of shifts) a doctor is to do each year and not specify a number of days or hours of vacation time. For more detail, read “The Vacation Conundrum” from March 2007.

 

 

If your practice has a vacation system that works well, then stick with it. But if you or your administrators are going nuts trying to categorize nonworking days between vacation and days the doctor simply wasn’t scheduled, then it might be best to stop trying. Just settle on the number of shifts (or some other metric) that a doctor is to work each year.

Tenure-based salary increases. It makes a lot of sense to pay doctors in most specialties an increasing salary based on his or her tenure with the practice. As they build a patient population and a referral stream, they generate more revenue and should benefit accordingly. But a new hospitalist who joins an existing group almost never has to build the referrals. In most cases, the group hired the doctor because the referrals are already coming and the practice needs more help, or the new doctor is replacing a departing one. So paying a new hospitalist a lower salary that increases automatically every few years isn’t really a raise earned by the doctor’s improved financial performance. Usually it’s just a system of withholding money that could be available for compensation for the doctor’s first few years in the practice. This lower starting salary might adversely impact recruiting. For more, see “Compensation Conundrum” from December 2009.

Poor roles for nonphysician providers (NPPs). I’ve worked with a lot of practices that have NPs and PAs (and, in some cases, RNs) who are doing what amounts to clerical work. They’re faxing discharge summaries, making calls to schedule patient appointments, dividing up the overnight admissions for the day rounders, etc.

Don’t make this mistake. Hire a secretary for that sort of work. And be sure that the roles occupied by trained clinicians (PAs, NPs, RNs, etc.) are professionally satisfying and will position them to make an effective contribution to the practice.

For more on this topic, see “The 411 on NPPs” from September 2008 and “Role Refinement” from September 2009; the latter features the perspective of Ryan Genzink, a thoughtful PA-C from Michigan.

Blinded performance reporting. First, make sure your practice provides regular, meaningful reports on each doctor’s performance and the group as a whole. This usually takes the form of a dashboard or report card. In my experience, too few practices do this. Make sure your group isn’t in that category.

Groups that do provide performance data often allow each doctor to see only his or her data. If data about other individuals in the group are provided, the names have often been removed. With exception of certain human resources issues (e.g. counseling a doctor to prevent termination), I think all performance data in the group should be shared by name with the whole group. In most practices, everyone should know by name which doctors are the high and low producers, each doctor’s compensation, and CPT coding practices (e.g. the portion of discharges coded at the high level).

When clinical performance can be attributed to individual providers, report those metrics openly, too. This usually creates greater cohesion within the group and helps foster a mentality of practice ownership. TH

Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants a national hospitalist practice management consulting firm (www.nelsonflores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program.” This column represents his views and is not intended to reflect an official position of SHM.

Issue
The Hospitalist - 2011(04)
Issue
The Hospitalist - 2011(04)
Publications
Publications
Article Type
Display Headline
The To-Don’t List
Display Headline
The To-Don’t List
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

What is the optimal time to deliver a woman whohas placenta previa?

Article Type
Changed
Display Headline
What is the optimal time to deliver a woman whohas placenta previa?

Although placenta previa is relatively rare—affecting one in every 200 to 300 singleton gestations—it is associated with significant maternal morbidity and death. Between 1979 and 1992, for example, 6.6% of maternal deaths were caused by bleeding associated with placenta previa. Perinatal mortality is also high—occurring at a rate that is three to four times higher than in normal pregnancies.1,2

Zlatnick and colleagues have tackled a difficult issue in obstetrics, one that continues to spark debate among obstetricians—namely, when to optimally time the delivery of a patient who has placenta previa. They use a mathematical model that yields specific results based on very specific assumptions.Change the assumptions and the conclusions change, too. Although Zlatnick and colleagues have attempted to remain as fair and unbiased in their assumptions as possible, the reader must interpret their conclusions with caution.

Not all placenta previas are created equal

The mathematical model presented in this study is most relevant for truly uncomplicated placenta previa in an otherwise healthy gravida. Not all placenta previas are alike.

Despite this decision analysis, the role of amniocentesis remains unclear. The risk of respiratory distress syndrome (RDS) in an infant who has mature chemical indices is not much different than the a priori risk of RDS at 36 weeks’ gestation.

Another fact to consider: The role of maternal steroid administration to accelerate fetal lung maturity has not been firmly established beyond the 34th week of gestation.

Mathematical model is innovative but incomplete

Use of the “quality-adjusted life-year model” in this study is innovative. However, in my opinion, this decision analysis, although helpful, is incomplete.

The model has been used by two of the authors in a different decision analysis of optimal timing of delivery of women who have a prior classical cesarean section. Interestingly, in their conclusion, these authors arrived at exactly the same gestational age as the current study of placenta previa.3 That is surprising, given the entirely different biologies of placenta previa and rupture of a prior classical incision.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

I think that most clinicians would agree that 1) carrying a pregnancy complicated by placenta previa to 39 weeks’ gestation is not a good idea and 2) earlier delivery would certainly not be considered “elective.” Moreover, it would be unwise to attempt to temporize in the setting of a bleeding previa in the late third trimester.

I would also caution against elective near-term or late preterm delivery on the basis of this model—although I would suggest that an alternative worthy of consideration would be to delay delivery until 37 weeks, when the definition of “term” has been fulfilled.

The role of steroids in this setting has not been established, and the role of amniocentesis seems equally unclear.

Ultimately, we need to use sound clinical judgment and information from decision analyses like this one in counseling and obtaining true informed consent from the patient, who must be an active partner in the decision-making process. Like the obstetrician, she must arrive at a decision without clear guidance from properly conducted and adequately powered clinical trials.
JOHN T. REPKE, MD

We want to hear from you!  Tell us what you think.

References

1. Crane JM, Van den Hof MC, Dods L, Armson BA, Liston R. Neonatal outcomes with placenta previa. Obstet Gynecol. 1999;93(4):541-544.

2. Ananth CV, Smulian JC, Vintzileos AM. The effect of placenta previa on neonatal mortality: a population-based study in the United States 1989 through 1997. Am J Obstet Gynecol. 2003;188(5):1299-1304.

3. Stotland NE, Lipschitz LS, Caughey AB. Delivery strategies for women with a prior classic cesarean delivery: a decision analysis. Am J Obstet Gynecol. 2002;187(5):1203-1208.

Article PDF
Author and Disclosure Information

36 WEEKS, provided steroids were administered at 35 weeks and 5 days, with or without amniocentesis to confirm fetal lung maturity, according to this decision analysis.

Zlatnick MG, Little SE, Kohli P, Kaimal AJ, Stotland NE, Caughey AB. When should women with placenta previa be delivered? A decision analysis. J Reprod Med. 2010;55(9–10):373–381.

EXPERT COMMENTARY

John T. Repke, ,MD
Professor and Chair, Department of Obstetrics and Gynecology, Penn State College of Medicine–Milton S. Hershey Medical Center, Hershey, Pa. Dr. Repke serves on the OBG ManageMent Board of Editors.

Issue
OBG Management - 23(04)
Publications
Topics
Page Number
22-23
Legacy Keywords
optimal time to deliver;placenta previa;Examining the Evidence;John T. Repke MD;steroids;amniocentesis;fetal lung maturity;maternal morbidity;perinatal mortality;mathematical model;respiratory distress syndrome;RDS;36 weeks' gestation;quality-adjusted life-year model;optimal timing of delivery;gestational age;preterm delivery;Zlatnick;singleton gestation;
Sections
Author and Disclosure Information

36 WEEKS, provided steroids were administered at 35 weeks and 5 days, with or without amniocentesis to confirm fetal lung maturity, according to this decision analysis.

Zlatnick MG, Little SE, Kohli P, Kaimal AJ, Stotland NE, Caughey AB. When should women with placenta previa be delivered? A decision analysis. J Reprod Med. 2010;55(9–10):373–381.

EXPERT COMMENTARY

John T. Repke, ,MD
Professor and Chair, Department of Obstetrics and Gynecology, Penn State College of Medicine–Milton S. Hershey Medical Center, Hershey, Pa. Dr. Repke serves on the OBG ManageMent Board of Editors.

Author and Disclosure Information

36 WEEKS, provided steroids were administered at 35 weeks and 5 days, with or without amniocentesis to confirm fetal lung maturity, according to this decision analysis.

Zlatnick MG, Little SE, Kohli P, Kaimal AJ, Stotland NE, Caughey AB. When should women with placenta previa be delivered? A decision analysis. J Reprod Med. 2010;55(9–10):373–381.

EXPERT COMMENTARY

John T. Repke, ,MD
Professor and Chair, Department of Obstetrics and Gynecology, Penn State College of Medicine–Milton S. Hershey Medical Center, Hershey, Pa. Dr. Repke serves on the OBG ManageMent Board of Editors.

Article PDF
Article PDF

Although placenta previa is relatively rare—affecting one in every 200 to 300 singleton gestations—it is associated with significant maternal morbidity and death. Between 1979 and 1992, for example, 6.6% of maternal deaths were caused by bleeding associated with placenta previa. Perinatal mortality is also high—occurring at a rate that is three to four times higher than in normal pregnancies.1,2

Zlatnick and colleagues have tackled a difficult issue in obstetrics, one that continues to spark debate among obstetricians—namely, when to optimally time the delivery of a patient who has placenta previa. They use a mathematical model that yields specific results based on very specific assumptions.Change the assumptions and the conclusions change, too. Although Zlatnick and colleagues have attempted to remain as fair and unbiased in their assumptions as possible, the reader must interpret their conclusions with caution.

Not all placenta previas are created equal

The mathematical model presented in this study is most relevant for truly uncomplicated placenta previa in an otherwise healthy gravida. Not all placenta previas are alike.

Despite this decision analysis, the role of amniocentesis remains unclear. The risk of respiratory distress syndrome (RDS) in an infant who has mature chemical indices is not much different than the a priori risk of RDS at 36 weeks’ gestation.

Another fact to consider: The role of maternal steroid administration to accelerate fetal lung maturity has not been firmly established beyond the 34th week of gestation.

Mathematical model is innovative but incomplete

Use of the “quality-adjusted life-year model” in this study is innovative. However, in my opinion, this decision analysis, although helpful, is incomplete.

The model has been used by two of the authors in a different decision analysis of optimal timing of delivery of women who have a prior classical cesarean section. Interestingly, in their conclusion, these authors arrived at exactly the same gestational age as the current study of placenta previa.3 That is surprising, given the entirely different biologies of placenta previa and rupture of a prior classical incision.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

I think that most clinicians would agree that 1) carrying a pregnancy complicated by placenta previa to 39 weeks’ gestation is not a good idea and 2) earlier delivery would certainly not be considered “elective.” Moreover, it would be unwise to attempt to temporize in the setting of a bleeding previa in the late third trimester.

I would also caution against elective near-term or late preterm delivery on the basis of this model—although I would suggest that an alternative worthy of consideration would be to delay delivery until 37 weeks, when the definition of “term” has been fulfilled.

The role of steroids in this setting has not been established, and the role of amniocentesis seems equally unclear.

Ultimately, we need to use sound clinical judgment and information from decision analyses like this one in counseling and obtaining true informed consent from the patient, who must be an active partner in the decision-making process. Like the obstetrician, she must arrive at a decision without clear guidance from properly conducted and adequately powered clinical trials.
JOHN T. REPKE, MD

We want to hear from you!  Tell us what you think.

Although placenta previa is relatively rare—affecting one in every 200 to 300 singleton gestations—it is associated with significant maternal morbidity and death. Between 1979 and 1992, for example, 6.6% of maternal deaths were caused by bleeding associated with placenta previa. Perinatal mortality is also high—occurring at a rate that is three to four times higher than in normal pregnancies.1,2

Zlatnick and colleagues have tackled a difficult issue in obstetrics, one that continues to spark debate among obstetricians—namely, when to optimally time the delivery of a patient who has placenta previa. They use a mathematical model that yields specific results based on very specific assumptions.Change the assumptions and the conclusions change, too. Although Zlatnick and colleagues have attempted to remain as fair and unbiased in their assumptions as possible, the reader must interpret their conclusions with caution.

Not all placenta previas are created equal

The mathematical model presented in this study is most relevant for truly uncomplicated placenta previa in an otherwise healthy gravida. Not all placenta previas are alike.

Despite this decision analysis, the role of amniocentesis remains unclear. The risk of respiratory distress syndrome (RDS) in an infant who has mature chemical indices is not much different than the a priori risk of RDS at 36 weeks’ gestation.

Another fact to consider: The role of maternal steroid administration to accelerate fetal lung maturity has not been firmly established beyond the 34th week of gestation.

Mathematical model is innovative but incomplete

Use of the “quality-adjusted life-year model” in this study is innovative. However, in my opinion, this decision analysis, although helpful, is incomplete.

The model has been used by two of the authors in a different decision analysis of optimal timing of delivery of women who have a prior classical cesarean section. Interestingly, in their conclusion, these authors arrived at exactly the same gestational age as the current study of placenta previa.3 That is surprising, given the entirely different biologies of placenta previa and rupture of a prior classical incision.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

I think that most clinicians would agree that 1) carrying a pregnancy complicated by placenta previa to 39 weeks’ gestation is not a good idea and 2) earlier delivery would certainly not be considered “elective.” Moreover, it would be unwise to attempt to temporize in the setting of a bleeding previa in the late third trimester.

I would also caution against elective near-term or late preterm delivery on the basis of this model—although I would suggest that an alternative worthy of consideration would be to delay delivery until 37 weeks, when the definition of “term” has been fulfilled.

The role of steroids in this setting has not been established, and the role of amniocentesis seems equally unclear.

Ultimately, we need to use sound clinical judgment and information from decision analyses like this one in counseling and obtaining true informed consent from the patient, who must be an active partner in the decision-making process. Like the obstetrician, she must arrive at a decision without clear guidance from properly conducted and adequately powered clinical trials.
JOHN T. REPKE, MD

We want to hear from you!  Tell us what you think.

References

1. Crane JM, Van den Hof MC, Dods L, Armson BA, Liston R. Neonatal outcomes with placenta previa. Obstet Gynecol. 1999;93(4):541-544.

2. Ananth CV, Smulian JC, Vintzileos AM. The effect of placenta previa on neonatal mortality: a population-based study in the United States 1989 through 1997. Am J Obstet Gynecol. 2003;188(5):1299-1304.

3. Stotland NE, Lipschitz LS, Caughey AB. Delivery strategies for women with a prior classic cesarean delivery: a decision analysis. Am J Obstet Gynecol. 2002;187(5):1203-1208.

References

1. Crane JM, Van den Hof MC, Dods L, Armson BA, Liston R. Neonatal outcomes with placenta previa. Obstet Gynecol. 1999;93(4):541-544.

2. Ananth CV, Smulian JC, Vintzileos AM. The effect of placenta previa on neonatal mortality: a population-based study in the United States 1989 through 1997. Am J Obstet Gynecol. 2003;188(5):1299-1304.

3. Stotland NE, Lipschitz LS, Caughey AB. Delivery strategies for women with a prior classic cesarean delivery: a decision analysis. Am J Obstet Gynecol. 2002;187(5):1203-1208.

Issue
OBG Management - 23(04)
Issue
OBG Management - 23(04)
Page Number
22-23
Page Number
22-23
Publications
Publications
Topics
Article Type
Display Headline
What is the optimal time to deliver a woman whohas placenta previa?
Display Headline
What is the optimal time to deliver a woman whohas placenta previa?
Legacy Keywords
optimal time to deliver;placenta previa;Examining the Evidence;John T. Repke MD;steroids;amniocentesis;fetal lung maturity;maternal morbidity;perinatal mortality;mathematical model;respiratory distress syndrome;RDS;36 weeks' gestation;quality-adjusted life-year model;optimal timing of delivery;gestational age;preterm delivery;Zlatnick;singleton gestation;
Legacy Keywords
optimal time to deliver;placenta previa;Examining the Evidence;John T. Repke MD;steroids;amniocentesis;fetal lung maturity;maternal morbidity;perinatal mortality;mathematical model;respiratory distress syndrome;RDS;36 weeks' gestation;quality-adjusted life-year model;optimal timing of delivery;gestational age;preterm delivery;Zlatnick;singleton gestation;
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Is population-based screening for endometrial cancer feasible?

Article Type
Changed
Display Headline
Is population-based screening for endometrial cancer feasible?

RELATED ARTICLE

Although endometrial cancer is the most common gynecologic malignancy in the United States, population-based screening has not been recommended. In this study—the only large-scale study to focus on the use of TVS in endometrial cancer screening—Jacobs and colleagues correlated endometrial thickness and any endometrial abnormalities detected during screening with a subsequent diagnosis of endometrial neoplasia (cancer or atypical hyperplasia). In an analysis of 96 asymptomatic women who were found to have endometrial neoplasia at the time of TVS, a cutoff for endometrial thickness of 5 mm or more was associated with 77.1% sensitivity and 85.8% specificity.

Among the variables associated with a higher risk of endometrial neoplasia were weight, age, and a personal history of breast cancer. Among those associated with a lower risk of neoplasia were use of oral contraceptives, age at menarche, and parity.

Jacobs and colleagues used these risk factors to divide women into quartiles. Women in the highest quartile had a relative risk (RR) of endometrial neoplasia of 1.98, and 39.5% of cases fell into this quartile. In this quartile, a cutoff for endometrial thickness of 6.75 mm or more was associated with sensitivity of 84.3% and specificity of 89.9%.

One finding is inexplicable

In an editorial accompanying this study, Vergote and colleagues call attention to what they consider to be an inexplicable finding: The optimal cutoff for endometrial thickness in the highest-risk quartile was greater than it was for the lower-risk women.1 They also point to the lack of data on subsequent procedures, such as endometrial biopsy and hysteroscopy, in women who had falsely positive TVS findings. And they emphasize their belief that the study should not lead clinicians to perform biopsies in asymptomatic women who are found to have an endometrial thickness greater than 5 mm.

Last, the editorialists, all of whom are gynecologic oncologists, appropriately point out that not all endometrial neoplasia is life-threatening. Therefore, the long-term survival advantage of detecting endometrial neoplasia in asymptomatic women is uncertain.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

The findings of Jacobs and colleagues form the basis for further large-scale study of screening for endometrial cancer in asymptomatic women. But until such studies are conducted and reported (and then only if findings support a benefit from screening), there is no justification for screening asymptomatic postmenopausal women using TVS.
—ANDREW M. KAUNITZ, MD

We want to hear from you!  Tell us what you think.

References

1. Vergote I, Amant F, Timmerman D. Should we screen for endometrial cancer? Lancet Oncol. 2011;12(1):4-5.

Article PDF
Author and Disclosure Information

NOT YET. This nested case-control study of 48,230 postmenopausal women who underwent transvaginal ultrasonography (TVS) as part of the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) found that TVS screening of asymptomatic women has sensitivity of 77% to 90% and similar levels of specificity, suggesting that population screening may be feasible one day.

In the meantime, the authors conclude: “We do not advocate population screening for endometrial cancer until further data are available.”

Jacobs I, Gentry-Maharaj A, Burnell M, et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol. 2011;12(1):38–48.

EXPERT COMMENTARY

Andrew M. Kaunitz, MD,
Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine–Jacksonville, Jacksonville, Fla. Dr. Kaunitz serves on the OBG Management Board of Editors.

Issue
OBG Management - 23(04)
Publications
Topics
Page Number
53-54
Legacy Keywords
Is population-based screening for endometrial cancer feasible;Examining the Evidence;Andrew M. Kaunitz MD;transvaginal ultrasonography;TVS;United Kingdom Collaborative Trial of Ovarian Cancer Screening;UKCTOCS;population screening;endometrial cancer;endometrial thickness;endometrial neoplasia;oral contraceptives;asymptomatic postmenopausal women;
Sections
Author and Disclosure Information

NOT YET. This nested case-control study of 48,230 postmenopausal women who underwent transvaginal ultrasonography (TVS) as part of the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) found that TVS screening of asymptomatic women has sensitivity of 77% to 90% and similar levels of specificity, suggesting that population screening may be feasible one day.

In the meantime, the authors conclude: “We do not advocate population screening for endometrial cancer until further data are available.”

Jacobs I, Gentry-Maharaj A, Burnell M, et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol. 2011;12(1):38–48.

EXPERT COMMENTARY

Andrew M. Kaunitz, MD,
Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine–Jacksonville, Jacksonville, Fla. Dr. Kaunitz serves on the OBG Management Board of Editors.

Author and Disclosure Information

NOT YET. This nested case-control study of 48,230 postmenopausal women who underwent transvaginal ultrasonography (TVS) as part of the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) found that TVS screening of asymptomatic women has sensitivity of 77% to 90% and similar levels of specificity, suggesting that population screening may be feasible one day.

In the meantime, the authors conclude: “We do not advocate population screening for endometrial cancer until further data are available.”

Jacobs I, Gentry-Maharaj A, Burnell M, et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol. 2011;12(1):38–48.

EXPERT COMMENTARY

Andrew M. Kaunitz, MD,
Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine–Jacksonville, Jacksonville, Fla. Dr. Kaunitz serves on the OBG Management Board of Editors.

Article PDF
Article PDF

RELATED ARTICLE

Although endometrial cancer is the most common gynecologic malignancy in the United States, population-based screening has not been recommended. In this study—the only large-scale study to focus on the use of TVS in endometrial cancer screening—Jacobs and colleagues correlated endometrial thickness and any endometrial abnormalities detected during screening with a subsequent diagnosis of endometrial neoplasia (cancer or atypical hyperplasia). In an analysis of 96 asymptomatic women who were found to have endometrial neoplasia at the time of TVS, a cutoff for endometrial thickness of 5 mm or more was associated with 77.1% sensitivity and 85.8% specificity.

Among the variables associated with a higher risk of endometrial neoplasia were weight, age, and a personal history of breast cancer. Among those associated with a lower risk of neoplasia were use of oral contraceptives, age at menarche, and parity.

Jacobs and colleagues used these risk factors to divide women into quartiles. Women in the highest quartile had a relative risk (RR) of endometrial neoplasia of 1.98, and 39.5% of cases fell into this quartile. In this quartile, a cutoff for endometrial thickness of 6.75 mm or more was associated with sensitivity of 84.3% and specificity of 89.9%.

One finding is inexplicable

In an editorial accompanying this study, Vergote and colleagues call attention to what they consider to be an inexplicable finding: The optimal cutoff for endometrial thickness in the highest-risk quartile was greater than it was for the lower-risk women.1 They also point to the lack of data on subsequent procedures, such as endometrial biopsy and hysteroscopy, in women who had falsely positive TVS findings. And they emphasize their belief that the study should not lead clinicians to perform biopsies in asymptomatic women who are found to have an endometrial thickness greater than 5 mm.

Last, the editorialists, all of whom are gynecologic oncologists, appropriately point out that not all endometrial neoplasia is life-threatening. Therefore, the long-term survival advantage of detecting endometrial neoplasia in asymptomatic women is uncertain.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

The findings of Jacobs and colleagues form the basis for further large-scale study of screening for endometrial cancer in asymptomatic women. But until such studies are conducted and reported (and then only if findings support a benefit from screening), there is no justification for screening asymptomatic postmenopausal women using TVS.
—ANDREW M. KAUNITZ, MD

We want to hear from you!  Tell us what you think.

RELATED ARTICLE

Although endometrial cancer is the most common gynecologic malignancy in the United States, population-based screening has not been recommended. In this study—the only large-scale study to focus on the use of TVS in endometrial cancer screening—Jacobs and colleagues correlated endometrial thickness and any endometrial abnormalities detected during screening with a subsequent diagnosis of endometrial neoplasia (cancer or atypical hyperplasia). In an analysis of 96 asymptomatic women who were found to have endometrial neoplasia at the time of TVS, a cutoff for endometrial thickness of 5 mm or more was associated with 77.1% sensitivity and 85.8% specificity.

Among the variables associated with a higher risk of endometrial neoplasia were weight, age, and a personal history of breast cancer. Among those associated with a lower risk of neoplasia were use of oral contraceptives, age at menarche, and parity.

Jacobs and colleagues used these risk factors to divide women into quartiles. Women in the highest quartile had a relative risk (RR) of endometrial neoplasia of 1.98, and 39.5% of cases fell into this quartile. In this quartile, a cutoff for endometrial thickness of 6.75 mm or more was associated with sensitivity of 84.3% and specificity of 89.9%.

One finding is inexplicable

In an editorial accompanying this study, Vergote and colleagues call attention to what they consider to be an inexplicable finding: The optimal cutoff for endometrial thickness in the highest-risk quartile was greater than it was for the lower-risk women.1 They also point to the lack of data on subsequent procedures, such as endometrial biopsy and hysteroscopy, in women who had falsely positive TVS findings. And they emphasize their belief that the study should not lead clinicians to perform biopsies in asymptomatic women who are found to have an endometrial thickness greater than 5 mm.

Last, the editorialists, all of whom are gynecologic oncologists, appropriately point out that not all endometrial neoplasia is life-threatening. Therefore, the long-term survival advantage of detecting endometrial neoplasia in asymptomatic women is uncertain.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

The findings of Jacobs and colleagues form the basis for further large-scale study of screening for endometrial cancer in asymptomatic women. But until such studies are conducted and reported (and then only if findings support a benefit from screening), there is no justification for screening asymptomatic postmenopausal women using TVS.
—ANDREW M. KAUNITZ, MD

We want to hear from you!  Tell us what you think.

References

1. Vergote I, Amant F, Timmerman D. Should we screen for endometrial cancer? Lancet Oncol. 2011;12(1):4-5.

References

1. Vergote I, Amant F, Timmerman D. Should we screen for endometrial cancer? Lancet Oncol. 2011;12(1):4-5.

Issue
OBG Management - 23(04)
Issue
OBG Management - 23(04)
Page Number
53-54
Page Number
53-54
Publications
Publications
Topics
Article Type
Display Headline
Is population-based screening for endometrial cancer feasible?
Display Headline
Is population-based screening for endometrial cancer feasible?
Legacy Keywords
Is population-based screening for endometrial cancer feasible;Examining the Evidence;Andrew M. Kaunitz MD;transvaginal ultrasonography;TVS;United Kingdom Collaborative Trial of Ovarian Cancer Screening;UKCTOCS;population screening;endometrial cancer;endometrial thickness;endometrial neoplasia;oral contraceptives;asymptomatic postmenopausal women;
Legacy Keywords
Is population-based screening for endometrial cancer feasible;Examining the Evidence;Andrew M. Kaunitz MD;transvaginal ultrasonography;TVS;United Kingdom Collaborative Trial of Ovarian Cancer Screening;UKCTOCS;population screening;endometrial cancer;endometrial thickness;endometrial neoplasia;oral contraceptives;asymptomatic postmenopausal women;
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Is the annual pelvic exam a relic or a requisite?

Article Type
Changed
Display Headline
Is the annual pelvic exam a relic or a requisite?

The annual pelvic examination has been in the spotlight lately. After a commentary questioning its value was published early this year in the Journal of Women’s Health, the Wall Street Journal highlighted the controversy in its own high-profile article.1,2

At issue is a simple question: Does the pelvic examination deter women from seeking gynecologic care?

Some argue that the exam is so unpleasant that many women avoid their doctor’s office rather than undergo it. Here is the Wall Street Journal’s take on the issue. It’s the first line of its article on the subject:

Of all the indignities that women endure in their lives, one of the most dreaded is the routine pelvic exam.

The authors of the original commentary in the Journal of Women’s Health are a bit more circumspect. Carolyn L. Westhoff, MD, MSc, and colleagues discuss the reasons that a pelvic examination is traditionally performed—to detect sexually transmitted disease, clear a woman for contraception, and screen for cancer—and present evidence suggesting that these indications for the pelvic exam are no longer absolute in asymptomatic women.1

For example, Chlamydia can be identified in a culture obtained from urine or on vaginal swabs collected by the patient herself. Birth control pills can be prescribed without examining the patient as long as she is in good health and reports no problems. And evidence suggests that the pelvic exam—including bimanual palpation—does not increase the detection of ovarian cancer in asymptomatic women.

And now that ACOG has raised the minimum age for cervical cancer screening to 21 years and extended intervals between Pap tests for women who have normal results, there is no reason to examine the cervix every year, Dr. Westhoff and colleagues argue. In young women, annual inspection is unnecessary because cervical dysplasia tends to be transient, and, in older women, cervical inspection is unnecessary because a simple human papillomavirus (HPV) test can yield just as much information as a Pap smear and can be conducted on self-collected vaginal swabs.

So the question remains: Is the annual pelvic exam really required?

I would argue that the answer is “Yes.”

The pelvic examination offers many benefits

I find the pelvic exam to be indispensable in the assessment of the vulva, vagina, pelvic floor, and sexual function—and it yields information I often cannot obtain in any other way. For example, some vulvar lesions produce no symptoms but still pose a risk of cancer or represent a developing problem such as lichen sclerosis, but I cannot identify them unless I see them.

The physical examination of tissue also prompts me to ask focused questions, frequently about things the patient is too embarrassed to bring up herself. For example, I may examine a woman and find a cystocele or urethrocele. If she hasn’t mentioned leaking urine or other difficulties, the discovery prompts me to ask more specifically about these symptoms. When I do, I often uncover a significant source of distress that, for whatever reason, the patient did not report herself.

Other examples: On occasion, during the pelvic examination, I discover vaginismus. That finding prompts me to ask about painful sex. And sometimes a perimenopausal woman has dry vaginal tissue that is not bothersome…yet. By identifying this condition early, I can suggest interventions that prevent the dryness from becoming bothersome.

Validation is another benefit of the pelvic exam. For example, some younger women think they “look weird” or have something wrong with their body, and my reassurance that everything is totally normal can greatly ease their mind.


The power of ritual

In a New York Times article about the need to focus on the actual patient rather than simply the data in her chart, Abraham Verghese, MD, relates the story of an elderly patient whose daughter was resistant to his recommendations until she watched him perform a comprehensive physical exam.3 The medical team discussed the case afterward and concluded that “the daughter witnessing the examination of the patient, that ritual, was the key to earning both their trusts.”3

“I find that patients from almost any culture have deep expectations of a ritual when a doctor sees them,” Dr. Verghese writes, “and they are quick to perceive when he or she gives those procedures short shrift by, say, placing the stethoscope on top of the gown instead of the skin, doing a cursory prod of the belly and wrapping up in 30 seconds.”3

I agree. Patients can be very resistant to our recommendations if they feel they have gotten substandard evaluation. And part of their expectation of evaluation is a physical examination. There is a sense of connection and closeness that patients have come to count on. And they can tell when we are not placing enough emphasis on this aspect of care.

 

 

Another argument in favor of the pelvic exam: I see at least one patient every day who is referred to me by her primary care doctor and who has not, over the course of her care for the current complaint, had to take off her clothes for a comprehensive examination. She typically is sent to me because of a finding on magnetic resonance imaging (MRI) or computed tomography (CT). Not uncommonly, women are convinced they have cancer based on these incidental findings. Yet those findings usually turn out to be a perfectly benign entity of little consequence, such as a benign fibroid tumor of the uterus. The power of the physical exam is that it can document things such as fibroids before they turn up on an MRI or CT scan. That is much less stressful for the patient than having a mysterious lesion identified on imaging, necessitating referral to a specialist to identify the problem.

No barriers to care

I don’t think women like the pelvic exam any more than they like mammograms or being physically vulnerable in any way. In my experience, however, patients tend to experience more trepidation about stepping onto the scale than about undergoing a pelvic exam.

Am I going to create a barrier to a patient’s care by insisting on weighing her or on performing a pelvic exam after she voices her desire to avoid these things?

Of course not.

Certainly, if a patient declines either of these options, I honor her wishes. However, I make it a point to have a conversation with her about their intrinsic value.

I try to teach my patients that they are the owners of their bodies, and that everything that occurs in the doctor-patient relationship is collaborative. In my practice, women always have the option to say “No.”

I do agree with Dr. Westhoff and colleagues that some women are turned off by the prospect of a pelvic exam. Adolescents, in particular, are often apprehensive about it. When I see a teenager for her first gynecologic visit, I usually focus on discussion. I try to get to know her and attempt to give her a sense of control over her own body. When it comes to the pelvic exam, I give her a choice—and I honor her decision.

Other patients who may be unwilling to undergo an annual pelvic exam include women who have a history of sexual abuse or molestation. Again, I respect their wishes, but I do talk to them about the value of the physical.

Unlike Dr. Westhoff and colleagues, however, I don’t believe that “no annual pelvic exam” should be our default position. And although there are other components of gynecologic care to see to besides the pelvic exam, I don’t think the exam should be dispensed with in the interest of saving time. In actuality, the pelvic exam is probably the least time-consuming aspect of gynecologic care for an asymptomatic patient.

In my view, the purpose of the annual visit is to identify risks and manage them—and some risks may be overlooked if I don’t have the opportunity to examine the patient. At the annual well woman visit, I have a conversation with the patient about the risks she faces over the next year, depending on her age and overall condition, and I devote quite a bit of time to this discussion. But I don’t do it at the expense of a careful pelvic exam.

Instead, I honor the ritual and the critical information it yields.


INSTANT POLL: A patient arrives for her annual well-woman examination. What do you do?
To read the entire question, enter your response, and see how others have answered, click on the blue title.


We want to hear from you! Tell us what you think.

References

1. Westhoff CL, Jones HE, Guiahi M. Do new guidelines and technology make the routine pelvic examination obsolete? J Women’s Health. 2011;20(1):5-10.

2. Beck M. Questioning the need for routine pelvic exam. Wall Street Journal. February 15 2011. http://online.wsj.com/article/SB10001424052748703584804576144161119909004.html. Accessed March 10, 2011.

3. Verghese A. Treat the patient not the CT scan. New York Times. February 26, 2011.http://www.nytimes.com/2011/02/27/opinion/27verghese.html. Accessed March 14, 2011.

Article PDF
Author and Disclosure Information


Barbara S. Levy, MD
Dr. Levy is Medical Director of Women’s Health, Franciscan Health System, Tacoma, Wash. She serves on the OBG Management Board of Editors.
Dr. Levy reports no financial relationships relevant to this article.

Issue
OBG Management - 23(04)
Publications
Topics
Page Number
14-20
Legacy Keywords
Is the annual pelvic exam a relic or a requisite;Commentary;Barbara S. Levy MD;asymptomatic women;annual pelvic examination;Carolyn L. Westhoff;MD;sexually transmitted disease;contraception;cancer screening;bimanual palpation;ovarian cancer;ACOG;Pap test;vulvar lesions;incontinence;vaginismus;painful sex;dry vaginal tissue;Abraham Verghese;MD;fibroid tumor;mammogram;patient's choice;sexual abuse;molestation;doctor-patient relationship;perimenopause;cervix
Sections
Author and Disclosure Information


Barbara S. Levy, MD
Dr. Levy is Medical Director of Women’s Health, Franciscan Health System, Tacoma, Wash. She serves on the OBG Management Board of Editors.
Dr. Levy reports no financial relationships relevant to this article.

Author and Disclosure Information


Barbara S. Levy, MD
Dr. Levy is Medical Director of Women’s Health, Franciscan Health System, Tacoma, Wash. She serves on the OBG Management Board of Editors.
Dr. Levy reports no financial relationships relevant to this article.

Article PDF
Article PDF

The annual pelvic examination has been in the spotlight lately. After a commentary questioning its value was published early this year in the Journal of Women’s Health, the Wall Street Journal highlighted the controversy in its own high-profile article.1,2

At issue is a simple question: Does the pelvic examination deter women from seeking gynecologic care?

Some argue that the exam is so unpleasant that many women avoid their doctor’s office rather than undergo it. Here is the Wall Street Journal’s take on the issue. It’s the first line of its article on the subject:

Of all the indignities that women endure in their lives, one of the most dreaded is the routine pelvic exam.

The authors of the original commentary in the Journal of Women’s Health are a bit more circumspect. Carolyn L. Westhoff, MD, MSc, and colleagues discuss the reasons that a pelvic examination is traditionally performed—to detect sexually transmitted disease, clear a woman for contraception, and screen for cancer—and present evidence suggesting that these indications for the pelvic exam are no longer absolute in asymptomatic women.1

For example, Chlamydia can be identified in a culture obtained from urine or on vaginal swabs collected by the patient herself. Birth control pills can be prescribed without examining the patient as long as she is in good health and reports no problems. And evidence suggests that the pelvic exam—including bimanual palpation—does not increase the detection of ovarian cancer in asymptomatic women.

And now that ACOG has raised the minimum age for cervical cancer screening to 21 years and extended intervals between Pap tests for women who have normal results, there is no reason to examine the cervix every year, Dr. Westhoff and colleagues argue. In young women, annual inspection is unnecessary because cervical dysplasia tends to be transient, and, in older women, cervical inspection is unnecessary because a simple human papillomavirus (HPV) test can yield just as much information as a Pap smear and can be conducted on self-collected vaginal swabs.

So the question remains: Is the annual pelvic exam really required?

I would argue that the answer is “Yes.”

The pelvic examination offers many benefits

I find the pelvic exam to be indispensable in the assessment of the vulva, vagina, pelvic floor, and sexual function—and it yields information I often cannot obtain in any other way. For example, some vulvar lesions produce no symptoms but still pose a risk of cancer or represent a developing problem such as lichen sclerosis, but I cannot identify them unless I see them.

The physical examination of tissue also prompts me to ask focused questions, frequently about things the patient is too embarrassed to bring up herself. For example, I may examine a woman and find a cystocele or urethrocele. If she hasn’t mentioned leaking urine or other difficulties, the discovery prompts me to ask more specifically about these symptoms. When I do, I often uncover a significant source of distress that, for whatever reason, the patient did not report herself.

Other examples: On occasion, during the pelvic examination, I discover vaginismus. That finding prompts me to ask about painful sex. And sometimes a perimenopausal woman has dry vaginal tissue that is not bothersome…yet. By identifying this condition early, I can suggest interventions that prevent the dryness from becoming bothersome.

Validation is another benefit of the pelvic exam. For example, some younger women think they “look weird” or have something wrong with their body, and my reassurance that everything is totally normal can greatly ease their mind.


The power of ritual

In a New York Times article about the need to focus on the actual patient rather than simply the data in her chart, Abraham Verghese, MD, relates the story of an elderly patient whose daughter was resistant to his recommendations until she watched him perform a comprehensive physical exam.3 The medical team discussed the case afterward and concluded that “the daughter witnessing the examination of the patient, that ritual, was the key to earning both their trusts.”3

“I find that patients from almost any culture have deep expectations of a ritual when a doctor sees them,” Dr. Verghese writes, “and they are quick to perceive when he or she gives those procedures short shrift by, say, placing the stethoscope on top of the gown instead of the skin, doing a cursory prod of the belly and wrapping up in 30 seconds.”3

I agree. Patients can be very resistant to our recommendations if they feel they have gotten substandard evaluation. And part of their expectation of evaluation is a physical examination. There is a sense of connection and closeness that patients have come to count on. And they can tell when we are not placing enough emphasis on this aspect of care.

 

 

Another argument in favor of the pelvic exam: I see at least one patient every day who is referred to me by her primary care doctor and who has not, over the course of her care for the current complaint, had to take off her clothes for a comprehensive examination. She typically is sent to me because of a finding on magnetic resonance imaging (MRI) or computed tomography (CT). Not uncommonly, women are convinced they have cancer based on these incidental findings. Yet those findings usually turn out to be a perfectly benign entity of little consequence, such as a benign fibroid tumor of the uterus. The power of the physical exam is that it can document things such as fibroids before they turn up on an MRI or CT scan. That is much less stressful for the patient than having a mysterious lesion identified on imaging, necessitating referral to a specialist to identify the problem.

No barriers to care

I don’t think women like the pelvic exam any more than they like mammograms or being physically vulnerable in any way. In my experience, however, patients tend to experience more trepidation about stepping onto the scale than about undergoing a pelvic exam.

Am I going to create a barrier to a patient’s care by insisting on weighing her or on performing a pelvic exam after she voices her desire to avoid these things?

Of course not.

Certainly, if a patient declines either of these options, I honor her wishes. However, I make it a point to have a conversation with her about their intrinsic value.

I try to teach my patients that they are the owners of their bodies, and that everything that occurs in the doctor-patient relationship is collaborative. In my practice, women always have the option to say “No.”

I do agree with Dr. Westhoff and colleagues that some women are turned off by the prospect of a pelvic exam. Adolescents, in particular, are often apprehensive about it. When I see a teenager for her first gynecologic visit, I usually focus on discussion. I try to get to know her and attempt to give her a sense of control over her own body. When it comes to the pelvic exam, I give her a choice—and I honor her decision.

Other patients who may be unwilling to undergo an annual pelvic exam include women who have a history of sexual abuse or molestation. Again, I respect their wishes, but I do talk to them about the value of the physical.

Unlike Dr. Westhoff and colleagues, however, I don’t believe that “no annual pelvic exam” should be our default position. And although there are other components of gynecologic care to see to besides the pelvic exam, I don’t think the exam should be dispensed with in the interest of saving time. In actuality, the pelvic exam is probably the least time-consuming aspect of gynecologic care for an asymptomatic patient.

In my view, the purpose of the annual visit is to identify risks and manage them—and some risks may be overlooked if I don’t have the opportunity to examine the patient. At the annual well woman visit, I have a conversation with the patient about the risks she faces over the next year, depending on her age and overall condition, and I devote quite a bit of time to this discussion. But I don’t do it at the expense of a careful pelvic exam.

Instead, I honor the ritual and the critical information it yields.


INSTANT POLL: A patient arrives for her annual well-woman examination. What do you do?
To read the entire question, enter your response, and see how others have answered, click on the blue title.


We want to hear from you! Tell us what you think.

The annual pelvic examination has been in the spotlight lately. After a commentary questioning its value was published early this year in the Journal of Women’s Health, the Wall Street Journal highlighted the controversy in its own high-profile article.1,2

At issue is a simple question: Does the pelvic examination deter women from seeking gynecologic care?

Some argue that the exam is so unpleasant that many women avoid their doctor’s office rather than undergo it. Here is the Wall Street Journal’s take on the issue. It’s the first line of its article on the subject:

Of all the indignities that women endure in their lives, one of the most dreaded is the routine pelvic exam.

The authors of the original commentary in the Journal of Women’s Health are a bit more circumspect. Carolyn L. Westhoff, MD, MSc, and colleagues discuss the reasons that a pelvic examination is traditionally performed—to detect sexually transmitted disease, clear a woman for contraception, and screen for cancer—and present evidence suggesting that these indications for the pelvic exam are no longer absolute in asymptomatic women.1

For example, Chlamydia can be identified in a culture obtained from urine or on vaginal swabs collected by the patient herself. Birth control pills can be prescribed without examining the patient as long as she is in good health and reports no problems. And evidence suggests that the pelvic exam—including bimanual palpation—does not increase the detection of ovarian cancer in asymptomatic women.

And now that ACOG has raised the minimum age for cervical cancer screening to 21 years and extended intervals between Pap tests for women who have normal results, there is no reason to examine the cervix every year, Dr. Westhoff and colleagues argue. In young women, annual inspection is unnecessary because cervical dysplasia tends to be transient, and, in older women, cervical inspection is unnecessary because a simple human papillomavirus (HPV) test can yield just as much information as a Pap smear and can be conducted on self-collected vaginal swabs.

So the question remains: Is the annual pelvic exam really required?

I would argue that the answer is “Yes.”

The pelvic examination offers many benefits

I find the pelvic exam to be indispensable in the assessment of the vulva, vagina, pelvic floor, and sexual function—and it yields information I often cannot obtain in any other way. For example, some vulvar lesions produce no symptoms but still pose a risk of cancer or represent a developing problem such as lichen sclerosis, but I cannot identify them unless I see them.

The physical examination of tissue also prompts me to ask focused questions, frequently about things the patient is too embarrassed to bring up herself. For example, I may examine a woman and find a cystocele or urethrocele. If she hasn’t mentioned leaking urine or other difficulties, the discovery prompts me to ask more specifically about these symptoms. When I do, I often uncover a significant source of distress that, for whatever reason, the patient did not report herself.

Other examples: On occasion, during the pelvic examination, I discover vaginismus. That finding prompts me to ask about painful sex. And sometimes a perimenopausal woman has dry vaginal tissue that is not bothersome…yet. By identifying this condition early, I can suggest interventions that prevent the dryness from becoming bothersome.

Validation is another benefit of the pelvic exam. For example, some younger women think they “look weird” or have something wrong with their body, and my reassurance that everything is totally normal can greatly ease their mind.


The power of ritual

In a New York Times article about the need to focus on the actual patient rather than simply the data in her chart, Abraham Verghese, MD, relates the story of an elderly patient whose daughter was resistant to his recommendations until she watched him perform a comprehensive physical exam.3 The medical team discussed the case afterward and concluded that “the daughter witnessing the examination of the patient, that ritual, was the key to earning both their trusts.”3

“I find that patients from almost any culture have deep expectations of a ritual when a doctor sees them,” Dr. Verghese writes, “and they are quick to perceive when he or she gives those procedures short shrift by, say, placing the stethoscope on top of the gown instead of the skin, doing a cursory prod of the belly and wrapping up in 30 seconds.”3

I agree. Patients can be very resistant to our recommendations if they feel they have gotten substandard evaluation. And part of their expectation of evaluation is a physical examination. There is a sense of connection and closeness that patients have come to count on. And they can tell when we are not placing enough emphasis on this aspect of care.

 

 

Another argument in favor of the pelvic exam: I see at least one patient every day who is referred to me by her primary care doctor and who has not, over the course of her care for the current complaint, had to take off her clothes for a comprehensive examination. She typically is sent to me because of a finding on magnetic resonance imaging (MRI) or computed tomography (CT). Not uncommonly, women are convinced they have cancer based on these incidental findings. Yet those findings usually turn out to be a perfectly benign entity of little consequence, such as a benign fibroid tumor of the uterus. The power of the physical exam is that it can document things such as fibroids before they turn up on an MRI or CT scan. That is much less stressful for the patient than having a mysterious lesion identified on imaging, necessitating referral to a specialist to identify the problem.

No barriers to care

I don’t think women like the pelvic exam any more than they like mammograms or being physically vulnerable in any way. In my experience, however, patients tend to experience more trepidation about stepping onto the scale than about undergoing a pelvic exam.

Am I going to create a barrier to a patient’s care by insisting on weighing her or on performing a pelvic exam after she voices her desire to avoid these things?

Of course not.

Certainly, if a patient declines either of these options, I honor her wishes. However, I make it a point to have a conversation with her about their intrinsic value.

I try to teach my patients that they are the owners of their bodies, and that everything that occurs in the doctor-patient relationship is collaborative. In my practice, women always have the option to say “No.”

I do agree with Dr. Westhoff and colleagues that some women are turned off by the prospect of a pelvic exam. Adolescents, in particular, are often apprehensive about it. When I see a teenager for her first gynecologic visit, I usually focus on discussion. I try to get to know her and attempt to give her a sense of control over her own body. When it comes to the pelvic exam, I give her a choice—and I honor her decision.

Other patients who may be unwilling to undergo an annual pelvic exam include women who have a history of sexual abuse or molestation. Again, I respect their wishes, but I do talk to them about the value of the physical.

Unlike Dr. Westhoff and colleagues, however, I don’t believe that “no annual pelvic exam” should be our default position. And although there are other components of gynecologic care to see to besides the pelvic exam, I don’t think the exam should be dispensed with in the interest of saving time. In actuality, the pelvic exam is probably the least time-consuming aspect of gynecologic care for an asymptomatic patient.

In my view, the purpose of the annual visit is to identify risks and manage them—and some risks may be overlooked if I don’t have the opportunity to examine the patient. At the annual well woman visit, I have a conversation with the patient about the risks she faces over the next year, depending on her age and overall condition, and I devote quite a bit of time to this discussion. But I don’t do it at the expense of a careful pelvic exam.

Instead, I honor the ritual and the critical information it yields.


INSTANT POLL: A patient arrives for her annual well-woman examination. What do you do?
To read the entire question, enter your response, and see how others have answered, click on the blue title.


We want to hear from you! Tell us what you think.

References

1. Westhoff CL, Jones HE, Guiahi M. Do new guidelines and technology make the routine pelvic examination obsolete? J Women’s Health. 2011;20(1):5-10.

2. Beck M. Questioning the need for routine pelvic exam. Wall Street Journal. February 15 2011. http://online.wsj.com/article/SB10001424052748703584804576144161119909004.html. Accessed March 10, 2011.

3. Verghese A. Treat the patient not the CT scan. New York Times. February 26, 2011.http://www.nytimes.com/2011/02/27/opinion/27verghese.html. Accessed March 14, 2011.

References

1. Westhoff CL, Jones HE, Guiahi M. Do new guidelines and technology make the routine pelvic examination obsolete? J Women’s Health. 2011;20(1):5-10.

2. Beck M. Questioning the need for routine pelvic exam. Wall Street Journal. February 15 2011. http://online.wsj.com/article/SB10001424052748703584804576144161119909004.html. Accessed March 10, 2011.

3. Verghese A. Treat the patient not the CT scan. New York Times. February 26, 2011.http://www.nytimes.com/2011/02/27/opinion/27verghese.html. Accessed March 14, 2011.

Issue
OBG Management - 23(04)
Issue
OBG Management - 23(04)
Page Number
14-20
Page Number
14-20
Publications
Publications
Topics
Article Type
Display Headline
Is the annual pelvic exam a relic or a requisite?
Display Headline
Is the annual pelvic exam a relic or a requisite?
Legacy Keywords
Is the annual pelvic exam a relic or a requisite;Commentary;Barbara S. Levy MD;asymptomatic women;annual pelvic examination;Carolyn L. Westhoff;MD;sexually transmitted disease;contraception;cancer screening;bimanual palpation;ovarian cancer;ACOG;Pap test;vulvar lesions;incontinence;vaginismus;painful sex;dry vaginal tissue;Abraham Verghese;MD;fibroid tumor;mammogram;patient's choice;sexual abuse;molestation;doctor-patient relationship;perimenopause;cervix
Legacy Keywords
Is the annual pelvic exam a relic or a requisite;Commentary;Barbara S. Levy MD;asymptomatic women;annual pelvic examination;Carolyn L. Westhoff;MD;sexually transmitted disease;contraception;cancer screening;bimanual palpation;ovarian cancer;ACOG;Pap test;vulvar lesions;incontinence;vaginismus;painful sex;dry vaginal tissue;Abraham Verghese;MD;fibroid tumor;mammogram;patient's choice;sexual abuse;molestation;doctor-patient relationship;perimenopause;cervix
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Par Excellence

Article Type
Changed
Display Headline
Par Excellence

I’m often asked about the attributes associated with high-functioning practices, so I thought I’d offer a list of them in this column. I’ve written entire columns about some of them in prior issues of The Hospitalist, so I will provide only brief commentary about each of them here.

I think this list can serve as a valuable frame of reference for any hospitalist practice, though it is geared more toward nonacademic settings. It is based on my own career as a hospitalist, which spans more than 20 years, and 15 years’ work as a consultant with nearly 300 institutions around the country. While I think my experience has given me a valuable perspective, others might reasonably omit some attributes listed here or add others.

I believe the single most important measure of a practice is excellent outcomes for its patients. That said, all of the attributes I describe here have more to do with excellent operational, or business, performance. It is possible for a practice to have all of these attributes and still provide disappointing clinical quality for its patients, but that seems really unlikely to me. And even a practice that provides superior clinical care probably won’t be able to do so for long without high-functioning business operations.

I think each of these attributes might be a cause of a practice’s excellent performance, but it is possible that some are a result of it. They are listed in no particular order.

I think each of these attributes might be a cause of a practice’s excellent performance, but it is possible that some are a result of it.

A culture of practice ownership. The most important attribute associated with a high-functioning practice is that the providers in the group maintain a mindset of practice ownership. Even if you are employees of a hospital or other organization, you should think of yourselves as owners of the practice’s performance. When problems arise, you shouldn’t simply assume it is up to the practice leader alone, or an administrator outside of the practice to solve it. Instead, each doctor should always be thinking about how to improve the practice and taking action to make it happen. For more, see “Foster Ownership Culture” in the August 2008 issue, or visit my website and take a quiz (http://nelsonflores.com/html/quiz.html) to assess your ownership culture.

An effective group leader. All groups need a leader who takes the role seriously and doesn’t just view the job description as making the work schedule and attending more meetings than the other hospitalists. (Unfortunately, my experience is that this is precisely what a lot of leaders think.) Of the many markers that effective leaders display, one that seems pretty reliable to me is whether the group has routinely scheduled meetings, with an agenda provided in advance and minutes circulated a few days later. I wrote about effective group leaders in a June 2008 column titled “Follow the Money.”

Autonomy in making decisions. Even when you are an employee of a larger entity, the practice should be structured so that hospitalists have as much autonomy in decision-making as possible. For example, you should always be able to adjust the group’s work schedule (e.g. when shifts start and stop). You also should have a lot of say about your staffing and workload. The latter typically requires that the group is connected to the financial consequences of its choices, which usually means a compensation system based, to a significant degree, on productivity.

While still common for hospitalists, when the largest salary component is fixed, it will always follow that someone outside the group (e.g. an administrator at the hospital) will end up deciding how hard you will have to work to justify the promised salary. And the hospitalists will almost always find fault with that person’s decision—a recipe for constant frustration that inhibits the development of an ownership culture, among other things.

 

 

Each doctor sees the job as more than just providing care to patients. In addition to providing quality care for your patients, each hospitalist in the group must work to improve the performance of the hospital. This means work on clinical protocols, medical staff functions (e.g. credentials committee), documentation and coding for both CPT and DRG billing, etc.

Strong social connections. Every high-performing practice I’ve worked with is notable for the social connections between the hospitalists themselves, as well as between hospitalists and other physicians, nursing staff, and administrators. This shouldn’t be taken lightly. Social connections matter—a lot. And while the hospitalists in most groups feel reasonably connected with one another, too often they feel isolated from the other doctors and administrators at the hospital. I wrote some more thoughts about this in a June 2010 column, “Square Peg, Square Hole.”

Hospitalists actively involved in recruiting for their practice. The hospitalists themselves—at a minimum, the group leader—should be very involved in recruiting new members for the group. Professional recruiters are very valuable but can be a lot more effective if the hospitalists themselves participate in the process. The group will land better candidates that way. For more, see “We’re Hiring,” from July 2008.

Join Team Hospitalist

Want to share your unique perspective on hot topics in HM? Team Hospitalist is accepting applications for two-year terms beginning in April. If you are interested in joining the team, e-mail Editor Jason Carris at [email protected].

Hospitalists know data about their performance. Too many practices fail to provide routine data about each provider’s clinical and financial performance. Make sure your group isn’t in this category. Develop a routine report of key metrics for your practice. Usually it is fine, and best, to provide to the whole group unblinded performance data about each individual hospitalist. For more information, check out “Measuring Hospitalist Performance: Metrics, Reports, and Dashboards” on the SHM website.

Don’t rely solely on consensus-based decision-making. Relying on consensus is reasonable for most decisions, if a group has about eight to 10 members. Larger groups need to decide how they’ll make decisions if consensus can’t be reached easily. And they need to have the discipline to stick to their agreed upon process, usually a vote. For more on this subject, see “Play by the Rules” in the December 2007 issue. TH

Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is also course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program” course. This column represents his views and is not intended to reflect an official position of SHM.

Issue
The Hospitalist - 2011(03)
Publications
Sections

I’m often asked about the attributes associated with high-functioning practices, so I thought I’d offer a list of them in this column. I’ve written entire columns about some of them in prior issues of The Hospitalist, so I will provide only brief commentary about each of them here.

I think this list can serve as a valuable frame of reference for any hospitalist practice, though it is geared more toward nonacademic settings. It is based on my own career as a hospitalist, which spans more than 20 years, and 15 years’ work as a consultant with nearly 300 institutions around the country. While I think my experience has given me a valuable perspective, others might reasonably omit some attributes listed here or add others.

I believe the single most important measure of a practice is excellent outcomes for its patients. That said, all of the attributes I describe here have more to do with excellent operational, or business, performance. It is possible for a practice to have all of these attributes and still provide disappointing clinical quality for its patients, but that seems really unlikely to me. And even a practice that provides superior clinical care probably won’t be able to do so for long without high-functioning business operations.

I think each of these attributes might be a cause of a practice’s excellent performance, but it is possible that some are a result of it. They are listed in no particular order.

I think each of these attributes might be a cause of a practice’s excellent performance, but it is possible that some are a result of it.

A culture of practice ownership. The most important attribute associated with a high-functioning practice is that the providers in the group maintain a mindset of practice ownership. Even if you are employees of a hospital or other organization, you should think of yourselves as owners of the practice’s performance. When problems arise, you shouldn’t simply assume it is up to the practice leader alone, or an administrator outside of the practice to solve it. Instead, each doctor should always be thinking about how to improve the practice and taking action to make it happen. For more, see “Foster Ownership Culture” in the August 2008 issue, or visit my website and take a quiz (http://nelsonflores.com/html/quiz.html) to assess your ownership culture.

An effective group leader. All groups need a leader who takes the role seriously and doesn’t just view the job description as making the work schedule and attending more meetings than the other hospitalists. (Unfortunately, my experience is that this is precisely what a lot of leaders think.) Of the many markers that effective leaders display, one that seems pretty reliable to me is whether the group has routinely scheduled meetings, with an agenda provided in advance and minutes circulated a few days later. I wrote about effective group leaders in a June 2008 column titled “Follow the Money.”

Autonomy in making decisions. Even when you are an employee of a larger entity, the practice should be structured so that hospitalists have as much autonomy in decision-making as possible. For example, you should always be able to adjust the group’s work schedule (e.g. when shifts start and stop). You also should have a lot of say about your staffing and workload. The latter typically requires that the group is connected to the financial consequences of its choices, which usually means a compensation system based, to a significant degree, on productivity.

While still common for hospitalists, when the largest salary component is fixed, it will always follow that someone outside the group (e.g. an administrator at the hospital) will end up deciding how hard you will have to work to justify the promised salary. And the hospitalists will almost always find fault with that person’s decision—a recipe for constant frustration that inhibits the development of an ownership culture, among other things.

 

 

Each doctor sees the job as more than just providing care to patients. In addition to providing quality care for your patients, each hospitalist in the group must work to improve the performance of the hospital. This means work on clinical protocols, medical staff functions (e.g. credentials committee), documentation and coding for both CPT and DRG billing, etc.

Strong social connections. Every high-performing practice I’ve worked with is notable for the social connections between the hospitalists themselves, as well as between hospitalists and other physicians, nursing staff, and administrators. This shouldn’t be taken lightly. Social connections matter—a lot. And while the hospitalists in most groups feel reasonably connected with one another, too often they feel isolated from the other doctors and administrators at the hospital. I wrote some more thoughts about this in a June 2010 column, “Square Peg, Square Hole.”

Hospitalists actively involved in recruiting for their practice. The hospitalists themselves—at a minimum, the group leader—should be very involved in recruiting new members for the group. Professional recruiters are very valuable but can be a lot more effective if the hospitalists themselves participate in the process. The group will land better candidates that way. For more, see “We’re Hiring,” from July 2008.

Join Team Hospitalist

Want to share your unique perspective on hot topics in HM? Team Hospitalist is accepting applications for two-year terms beginning in April. If you are interested in joining the team, e-mail Editor Jason Carris at [email protected].

Hospitalists know data about their performance. Too many practices fail to provide routine data about each provider’s clinical and financial performance. Make sure your group isn’t in this category. Develop a routine report of key metrics for your practice. Usually it is fine, and best, to provide to the whole group unblinded performance data about each individual hospitalist. For more information, check out “Measuring Hospitalist Performance: Metrics, Reports, and Dashboards” on the SHM website.

Don’t rely solely on consensus-based decision-making. Relying on consensus is reasonable for most decisions, if a group has about eight to 10 members. Larger groups need to decide how they’ll make decisions if consensus can’t be reached easily. And they need to have the discipline to stick to their agreed upon process, usually a vote. For more on this subject, see “Play by the Rules” in the December 2007 issue. TH

Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is also course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program” course. This column represents his views and is not intended to reflect an official position of SHM.

I’m often asked about the attributes associated with high-functioning practices, so I thought I’d offer a list of them in this column. I’ve written entire columns about some of them in prior issues of The Hospitalist, so I will provide only brief commentary about each of them here.

I think this list can serve as a valuable frame of reference for any hospitalist practice, though it is geared more toward nonacademic settings. It is based on my own career as a hospitalist, which spans more than 20 years, and 15 years’ work as a consultant with nearly 300 institutions around the country. While I think my experience has given me a valuable perspective, others might reasonably omit some attributes listed here or add others.

I believe the single most important measure of a practice is excellent outcomes for its patients. That said, all of the attributes I describe here have more to do with excellent operational, or business, performance. It is possible for a practice to have all of these attributes and still provide disappointing clinical quality for its patients, but that seems really unlikely to me. And even a practice that provides superior clinical care probably won’t be able to do so for long without high-functioning business operations.

I think each of these attributes might be a cause of a practice’s excellent performance, but it is possible that some are a result of it. They are listed in no particular order.

I think each of these attributes might be a cause of a practice’s excellent performance, but it is possible that some are a result of it.

A culture of practice ownership. The most important attribute associated with a high-functioning practice is that the providers in the group maintain a mindset of practice ownership. Even if you are employees of a hospital or other organization, you should think of yourselves as owners of the practice’s performance. When problems arise, you shouldn’t simply assume it is up to the practice leader alone, or an administrator outside of the practice to solve it. Instead, each doctor should always be thinking about how to improve the practice and taking action to make it happen. For more, see “Foster Ownership Culture” in the August 2008 issue, or visit my website and take a quiz (http://nelsonflores.com/html/quiz.html) to assess your ownership culture.

An effective group leader. All groups need a leader who takes the role seriously and doesn’t just view the job description as making the work schedule and attending more meetings than the other hospitalists. (Unfortunately, my experience is that this is precisely what a lot of leaders think.) Of the many markers that effective leaders display, one that seems pretty reliable to me is whether the group has routinely scheduled meetings, with an agenda provided in advance and minutes circulated a few days later. I wrote about effective group leaders in a June 2008 column titled “Follow the Money.”

Autonomy in making decisions. Even when you are an employee of a larger entity, the practice should be structured so that hospitalists have as much autonomy in decision-making as possible. For example, you should always be able to adjust the group’s work schedule (e.g. when shifts start and stop). You also should have a lot of say about your staffing and workload. The latter typically requires that the group is connected to the financial consequences of its choices, which usually means a compensation system based, to a significant degree, on productivity.

While still common for hospitalists, when the largest salary component is fixed, it will always follow that someone outside the group (e.g. an administrator at the hospital) will end up deciding how hard you will have to work to justify the promised salary. And the hospitalists will almost always find fault with that person’s decision—a recipe for constant frustration that inhibits the development of an ownership culture, among other things.

 

 

Each doctor sees the job as more than just providing care to patients. In addition to providing quality care for your patients, each hospitalist in the group must work to improve the performance of the hospital. This means work on clinical protocols, medical staff functions (e.g. credentials committee), documentation and coding for both CPT and DRG billing, etc.

Strong social connections. Every high-performing practice I’ve worked with is notable for the social connections between the hospitalists themselves, as well as between hospitalists and other physicians, nursing staff, and administrators. This shouldn’t be taken lightly. Social connections matter—a lot. And while the hospitalists in most groups feel reasonably connected with one another, too often they feel isolated from the other doctors and administrators at the hospital. I wrote some more thoughts about this in a June 2010 column, “Square Peg, Square Hole.”

Hospitalists actively involved in recruiting for their practice. The hospitalists themselves—at a minimum, the group leader—should be very involved in recruiting new members for the group. Professional recruiters are very valuable but can be a lot more effective if the hospitalists themselves participate in the process. The group will land better candidates that way. For more, see “We’re Hiring,” from July 2008.

Join Team Hospitalist

Want to share your unique perspective on hot topics in HM? Team Hospitalist is accepting applications for two-year terms beginning in April. If you are interested in joining the team, e-mail Editor Jason Carris at [email protected].

Hospitalists know data about their performance. Too many practices fail to provide routine data about each provider’s clinical and financial performance. Make sure your group isn’t in this category. Develop a routine report of key metrics for your practice. Usually it is fine, and best, to provide to the whole group unblinded performance data about each individual hospitalist. For more information, check out “Measuring Hospitalist Performance: Metrics, Reports, and Dashboards” on the SHM website.

Don’t rely solely on consensus-based decision-making. Relying on consensus is reasonable for most decisions, if a group has about eight to 10 members. Larger groups need to decide how they’ll make decisions if consensus can’t be reached easily. And they need to have the discipline to stick to their agreed upon process, usually a vote. For more on this subject, see “Play by the Rules” in the December 2007 issue. TH

Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is also course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program” course. This column represents his views and is not intended to reflect an official position of SHM.

Issue
The Hospitalist - 2011(03)
Issue
The Hospitalist - 2011(03)
Publications
Publications
Article Type
Display Headline
Par Excellence
Display Headline
Par Excellence
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

Are oral hypoglycemic agents equivalent to insulin in treating gestational diabetes?

Article Type
Changed
Display Headline
Are oral hypoglycemic agents equivalent to insulin in treating gestational diabetes?

RELATED ARTICLE

Although some still believe that GDM is a diagnosis looking for a disease, we have excellent evidence that the treatment of even mild forms of insulin resistance leads to improved maternal and neonatal outcomes.1,2 (See, for example, the article on GDM by E. Albert Reece, MD, PhD, MBA.) Treatment typically involves dietary modification, exercise, and, if necessary, injectable insulin. The most recent ACOG Practice Bulletin on GDM recommends that further studies be conducted before widespread use of oral hypoglycemic agents is initiated.3

The meta-analysis by Dhulkotia and colleagues compares “any” oral hypoglycemic agent (glyburide or metformin) with insulin and concludes that there is no difference between the two types of treatment. However, this conclusion can’t be drawn from the existing literature, and it is certainly nonsensical to conduct a meta-analysis in which both types of oral agents are combined. Studies that lump different medications with distinct mechanisms of action into the same category are unlikely to produce a coherent conclusion. In this meta-analysis, clinical heterogeneity likely exists because glyburide and metformin have entirely different modes of action.

When viewed in isolation, glyburide looks less promising

Let’s consider the literature on glyburide and metformin separately. All three studies comparing glyburide and insulin demonstrated a higher incidence of neonatal hypoglycemia among women taking glyburide, with one of those studies demonstrating a statistically significant effect. In contrast, the single large randomized, controlled study comparing metformin and insulin showed a non-significant reduction in the rate of neonatal hypoglycemia for women taking metformin. The combined effect of the oral agents in the meta-analysis is a nonsignificant increase in neonatal hypoglycemia, but the odds ratio is 1.59, which certainly has some clinical meaning. A similar clinical heterogeneity of the effect on birth weight is seen when the different oral agents are compared with insulin.

Overall, data on glyburide are confusing. Most studies find glyburide and insulin to be essentially equivalent for glycemic control, but insulin leads to better outcomes (although this effect is not significant, probably owing to insufficient power).4 The bias among many researchers exploring the use of glyburide for GDM is obvious. One study observed that glyburide was associated with a greater likelihood of neonatal hypoglycemia and higher birth weight than insulin, but still concluded that glyburide is a reasonable first-line therapy for GDM.5

Data on metformin are more promising.6 In the large prospective trial of metformin, the great majority of outcomes were essentially the same for both metformin and insulin. However, two findings give pause:

  • Approximately half the patients randomized to metformin eventually needed insulin to achieve adequate glucose control
  • There was a higher incidence of preterm birth (<37 weeks) in the metformin arm. Although neonatal complications did not occur at a statistically higher rate in the metformin group, the risk of preterm birth should certainly be mentioned to the patient before she is started on the medication.

Ease of use shouldn’t trump safety concerns

Over the past decade, it has become increasingly common for health-care providers to prescribe an oral agent instead of insulin for glycemic control—even though insulin remains the standard of care. I note a prevailing perception that oral agents are easier to use than insulin, thereby improving compliance. Oral agents are easier to prescribe and do not require extensive teaching, which does save time, including nonreimbursable office time. As a result, it makes economic sense to prescribe a pill.

In my experience, however, most pregnant women are adherent with insulin therapy, and insulin injection can be reliably taught and appropriately performed regardless of the patient’s socioeconomic status, education, or language. In terms of efficacy and safety, then, insulin remains our best option.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

Given the limitations of the studies conducted so far, I believe that insulin should remain first-line therapy in the treatment of gestational diabetes. The goal of treatment is not to achieve good control eventually, as metformin does, but to quickly achieve a state of euglycemia to minimize the effects of hyperglycemia on the fetus.

Some subpopulations of women who have GDM may be adequately treated with metformin—but identifying them remains difficult. Until we can be certain of the benefit-risk profile of oral hypoglycemic agents in pregnancy, their use should be limited to clinical studies.—AARON B. CAUGHEY, MD, PHD

INSTANT POLL: How would you treat this woman with gestational diabetes?
To read the entire question, enter your response, and see how others have answered, click on the blue title.

References

1. Landon MB, Spong CY, Thom E, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339-1348.

2. Crowther CA, Hiller JE, Moss JR, et al. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477-2486.

3. Gestational diabetes. ACOG Practice Bulletin#30. Obstet Gynecol. 2001;98(3):525-538.

4. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134-1138.

5. Silva JC, Bertini AM, Taborda W, et al. Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin [Portuguese]. Arq Bras Endocrinol Metabol. 2007;51(4):541-546.

6. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008; 358(19):2003-2015. Erratum in: N Engl J Med. 2008;359(1):106.-

Article PDF
Author and Disclosure Information

NO— Although the authors of a systematic review and meta-analysis conclude that they are. In fact, the preponderance of the evidence is that insulin remains the only first-line therapy for gestational diabetes mellitus (GDM).

Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic
agents vs insulin in management of gestational diabetes: a
systematic review and metaanalysis. Am J Obstet Gynecol.
2010;203(5):457.e1–9.

EXPERT COMMENTARY

Aaron B. Caughey, MD, PhD
Professor and Chair, Department of Obstetrics and Gynecology, and Julie Neupert Stott Director, Center for Women’s Health, Oregon Health & Science University, Portland, Oreg.

Issue
OBG Management - 23(03)
Publications
Topics
Page Number
14-15
Legacy Keywords
oral hypoglycemic agents;insulin;gestational diabetes;Aaron B Caughey MD;examining the evidence;improve outcomes;euglycemia;GDM;GDM testing guidelines;first-line therapy;insulin resistance;maternal outcomes;neonatal outcomes;Dhulkotia;glyburide;metformin;neonatal hypoglycemia;adequate glucose control;
Sections
Author and Disclosure Information

NO— Although the authors of a systematic review and meta-analysis conclude that they are. In fact, the preponderance of the evidence is that insulin remains the only first-line therapy for gestational diabetes mellitus (GDM).

Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic
agents vs insulin in management of gestational diabetes: a
systematic review and metaanalysis. Am J Obstet Gynecol.
2010;203(5):457.e1–9.

EXPERT COMMENTARY

Aaron B. Caughey, MD, PhD
Professor and Chair, Department of Obstetrics and Gynecology, and Julie Neupert Stott Director, Center for Women’s Health, Oregon Health & Science University, Portland, Oreg.

Author and Disclosure Information

NO— Although the authors of a systematic review and meta-analysis conclude that they are. In fact, the preponderance of the evidence is that insulin remains the only first-line therapy for gestational diabetes mellitus (GDM).

Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic
agents vs insulin in management of gestational diabetes: a
systematic review and metaanalysis. Am J Obstet Gynecol.
2010;203(5):457.e1–9.

EXPERT COMMENTARY

Aaron B. Caughey, MD, PhD
Professor and Chair, Department of Obstetrics and Gynecology, and Julie Neupert Stott Director, Center for Women’s Health, Oregon Health & Science University, Portland, Oreg.

Article PDF
Article PDF

RELATED ARTICLE

Although some still believe that GDM is a diagnosis looking for a disease, we have excellent evidence that the treatment of even mild forms of insulin resistance leads to improved maternal and neonatal outcomes.1,2 (See, for example, the article on GDM by E. Albert Reece, MD, PhD, MBA.) Treatment typically involves dietary modification, exercise, and, if necessary, injectable insulin. The most recent ACOG Practice Bulletin on GDM recommends that further studies be conducted before widespread use of oral hypoglycemic agents is initiated.3

The meta-analysis by Dhulkotia and colleagues compares “any” oral hypoglycemic agent (glyburide or metformin) with insulin and concludes that there is no difference between the two types of treatment. However, this conclusion can’t be drawn from the existing literature, and it is certainly nonsensical to conduct a meta-analysis in which both types of oral agents are combined. Studies that lump different medications with distinct mechanisms of action into the same category are unlikely to produce a coherent conclusion. In this meta-analysis, clinical heterogeneity likely exists because glyburide and metformin have entirely different modes of action.

When viewed in isolation, glyburide looks less promising

Let’s consider the literature on glyburide and metformin separately. All three studies comparing glyburide and insulin demonstrated a higher incidence of neonatal hypoglycemia among women taking glyburide, with one of those studies demonstrating a statistically significant effect. In contrast, the single large randomized, controlled study comparing metformin and insulin showed a non-significant reduction in the rate of neonatal hypoglycemia for women taking metformin. The combined effect of the oral agents in the meta-analysis is a nonsignificant increase in neonatal hypoglycemia, but the odds ratio is 1.59, which certainly has some clinical meaning. A similar clinical heterogeneity of the effect on birth weight is seen when the different oral agents are compared with insulin.

Overall, data on glyburide are confusing. Most studies find glyburide and insulin to be essentially equivalent for glycemic control, but insulin leads to better outcomes (although this effect is not significant, probably owing to insufficient power).4 The bias among many researchers exploring the use of glyburide for GDM is obvious. One study observed that glyburide was associated with a greater likelihood of neonatal hypoglycemia and higher birth weight than insulin, but still concluded that glyburide is a reasonable first-line therapy for GDM.5

Data on metformin are more promising.6 In the large prospective trial of metformin, the great majority of outcomes were essentially the same for both metformin and insulin. However, two findings give pause:

  • Approximately half the patients randomized to metformin eventually needed insulin to achieve adequate glucose control
  • There was a higher incidence of preterm birth (<37 weeks) in the metformin arm. Although neonatal complications did not occur at a statistically higher rate in the metformin group, the risk of preterm birth should certainly be mentioned to the patient before she is started on the medication.

Ease of use shouldn’t trump safety concerns

Over the past decade, it has become increasingly common for health-care providers to prescribe an oral agent instead of insulin for glycemic control—even though insulin remains the standard of care. I note a prevailing perception that oral agents are easier to use than insulin, thereby improving compliance. Oral agents are easier to prescribe and do not require extensive teaching, which does save time, including nonreimbursable office time. As a result, it makes economic sense to prescribe a pill.

In my experience, however, most pregnant women are adherent with insulin therapy, and insulin injection can be reliably taught and appropriately performed regardless of the patient’s socioeconomic status, education, or language. In terms of efficacy and safety, then, insulin remains our best option.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

Given the limitations of the studies conducted so far, I believe that insulin should remain first-line therapy in the treatment of gestational diabetes. The goal of treatment is not to achieve good control eventually, as metformin does, but to quickly achieve a state of euglycemia to minimize the effects of hyperglycemia on the fetus.

Some subpopulations of women who have GDM may be adequately treated with metformin—but identifying them remains difficult. Until we can be certain of the benefit-risk profile of oral hypoglycemic agents in pregnancy, their use should be limited to clinical studies.—AARON B. CAUGHEY, MD, PHD

INSTANT POLL: How would you treat this woman with gestational diabetes?
To read the entire question, enter your response, and see how others have answered, click on the blue title.

RELATED ARTICLE

Although some still believe that GDM is a diagnosis looking for a disease, we have excellent evidence that the treatment of even mild forms of insulin resistance leads to improved maternal and neonatal outcomes.1,2 (See, for example, the article on GDM by E. Albert Reece, MD, PhD, MBA.) Treatment typically involves dietary modification, exercise, and, if necessary, injectable insulin. The most recent ACOG Practice Bulletin on GDM recommends that further studies be conducted before widespread use of oral hypoglycemic agents is initiated.3

The meta-analysis by Dhulkotia and colleagues compares “any” oral hypoglycemic agent (glyburide or metformin) with insulin and concludes that there is no difference between the two types of treatment. However, this conclusion can’t be drawn from the existing literature, and it is certainly nonsensical to conduct a meta-analysis in which both types of oral agents are combined. Studies that lump different medications with distinct mechanisms of action into the same category are unlikely to produce a coherent conclusion. In this meta-analysis, clinical heterogeneity likely exists because glyburide and metformin have entirely different modes of action.

When viewed in isolation, glyburide looks less promising

Let’s consider the literature on glyburide and metformin separately. All three studies comparing glyburide and insulin demonstrated a higher incidence of neonatal hypoglycemia among women taking glyburide, with one of those studies demonstrating a statistically significant effect. In contrast, the single large randomized, controlled study comparing metformin and insulin showed a non-significant reduction in the rate of neonatal hypoglycemia for women taking metformin. The combined effect of the oral agents in the meta-analysis is a nonsignificant increase in neonatal hypoglycemia, but the odds ratio is 1.59, which certainly has some clinical meaning. A similar clinical heterogeneity of the effect on birth weight is seen when the different oral agents are compared with insulin.

Overall, data on glyburide are confusing. Most studies find glyburide and insulin to be essentially equivalent for glycemic control, but insulin leads to better outcomes (although this effect is not significant, probably owing to insufficient power).4 The bias among many researchers exploring the use of glyburide for GDM is obvious. One study observed that glyburide was associated with a greater likelihood of neonatal hypoglycemia and higher birth weight than insulin, but still concluded that glyburide is a reasonable first-line therapy for GDM.5

Data on metformin are more promising.6 In the large prospective trial of metformin, the great majority of outcomes were essentially the same for both metformin and insulin. However, two findings give pause:

  • Approximately half the patients randomized to metformin eventually needed insulin to achieve adequate glucose control
  • There was a higher incidence of preterm birth (<37 weeks) in the metformin arm. Although neonatal complications did not occur at a statistically higher rate in the metformin group, the risk of preterm birth should certainly be mentioned to the patient before she is started on the medication.

Ease of use shouldn’t trump safety concerns

Over the past decade, it has become increasingly common for health-care providers to prescribe an oral agent instead of insulin for glycemic control—even though insulin remains the standard of care. I note a prevailing perception that oral agents are easier to use than insulin, thereby improving compliance. Oral agents are easier to prescribe and do not require extensive teaching, which does save time, including nonreimbursable office time. As a result, it makes economic sense to prescribe a pill.

In my experience, however, most pregnant women are adherent with insulin therapy, and insulin injection can be reliably taught and appropriately performed regardless of the patient’s socioeconomic status, education, or language. In terms of efficacy and safety, then, insulin remains our best option.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

Given the limitations of the studies conducted so far, I believe that insulin should remain first-line therapy in the treatment of gestational diabetes. The goal of treatment is not to achieve good control eventually, as metformin does, but to quickly achieve a state of euglycemia to minimize the effects of hyperglycemia on the fetus.

Some subpopulations of women who have GDM may be adequately treated with metformin—but identifying them remains difficult. Until we can be certain of the benefit-risk profile of oral hypoglycemic agents in pregnancy, their use should be limited to clinical studies.—AARON B. CAUGHEY, MD, PHD

INSTANT POLL: How would you treat this woman with gestational diabetes?
To read the entire question, enter your response, and see how others have answered, click on the blue title.

References

1. Landon MB, Spong CY, Thom E, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339-1348.

2. Crowther CA, Hiller JE, Moss JR, et al. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477-2486.

3. Gestational diabetes. ACOG Practice Bulletin#30. Obstet Gynecol. 2001;98(3):525-538.

4. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134-1138.

5. Silva JC, Bertini AM, Taborda W, et al. Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin [Portuguese]. Arq Bras Endocrinol Metabol. 2007;51(4):541-546.

6. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008; 358(19):2003-2015. Erratum in: N Engl J Med. 2008;359(1):106.-

References

1. Landon MB, Spong CY, Thom E, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339-1348.

2. Crowther CA, Hiller JE, Moss JR, et al. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477-2486.

3. Gestational diabetes. ACOG Practice Bulletin#30. Obstet Gynecol. 2001;98(3):525-538.

4. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134-1138.

5. Silva JC, Bertini AM, Taborda W, et al. Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin [Portuguese]. Arq Bras Endocrinol Metabol. 2007;51(4):541-546.

6. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008; 358(19):2003-2015. Erratum in: N Engl J Med. 2008;359(1):106.-

Issue
OBG Management - 23(03)
Issue
OBG Management - 23(03)
Page Number
14-15
Page Number
14-15
Publications
Publications
Topics
Article Type
Display Headline
Are oral hypoglycemic agents equivalent to insulin in treating gestational diabetes?
Display Headline
Are oral hypoglycemic agents equivalent to insulin in treating gestational diabetes?
Legacy Keywords
oral hypoglycemic agents;insulin;gestational diabetes;Aaron B Caughey MD;examining the evidence;improve outcomes;euglycemia;GDM;GDM testing guidelines;first-line therapy;insulin resistance;maternal outcomes;neonatal outcomes;Dhulkotia;glyburide;metformin;neonatal hypoglycemia;adequate glucose control;
Legacy Keywords
oral hypoglycemic agents;insulin;gestational diabetes;Aaron B Caughey MD;examining the evidence;improve outcomes;euglycemia;GDM;GDM testing guidelines;first-line therapy;insulin resistance;maternal outcomes;neonatal outcomes;Dhulkotia;glyburide;metformin;neonatal hypoglycemia;adequate glucose control;
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Referral Lists

Article Type
Changed
Display Headline
Referral Lists

I like to ask laypeople what they think “hospitalist” means. For years, I was confident that they had never heard the term, but now my question is more often met with an accurate response.

A hotel desk clerk in 1998 actually made one of the cleverest guesses I’ve ever heard. For the whole day, she and her colleagues had in front of them a sign that read “Hospitalist Meeting in the Ballroom,” which got them talking about what in the world a hospitalist is. Seeing from my badge that I was attending that meeting, she asked me what the term meant, but she first gamely provided her best guess: “Someone who makes lists of hospitals.”

There seems to be no end to the number of healthcare-related nouns and verbs to which someone attaches the suffix “ist.” Some days I request so many consults that I’m just a “referralist” (one who refers patients; surely this is a term we can do without). But don’t let the headline of this column confuse you: I really am addressing the lists used to determine which doctor to refer patients to.

When there are competing providers in a given specialty, they will have an incentive to provide better service to the hospitalist as a way of ensuring future referrals.

Hospitalist Referrals

The first of two common referral lists for hospitalists is a directory of primary-care physicians (PCPs) and clinics, as well as some other providers that refer patients to the hospitalist. Nearly all hospitalist groups maintain such a list, and they might apply a variety of terms such as “subscriber” (which refers to hospitalists) and “nonsubscriber” physicians.

Because most HM groups care for patients who come from all or nearly all of the PCPs in an area, it is often simpler to just create a short list of those providers who don’t refer to the hospitalists. In many hospitals, there are just four or five providers on that list. ED providers are the ones who most often access this list. When visiting other hospitals, I often see a paper copy of the list taped up at the provider workstations in the ED.

Consult Who?

The other, and much less common, type of referral list governs which doctors the hospitalists are to consult. There are two strategies that come up when thinking about this kind of list.

Do what the ED doctors do. ED physicians typically are constrained by the list of on-call physicians for each specialty, and are to always consult that doctor rather than another. For example, the ED doctor is required to consult Dr. Taylor for any patient in need of a general surgeon and doesn’t have a prior relationship with one. Tomorrow, the ED doctor is required to consult Dr. Simon. Dr. Taylor and Dr. Simon are to be contacted because they are the ones on call for the ED those days. Even if the ED doctor would rather consult Dr. Simon today (maybe she is more able, affable, and available than Dr. Taylor), that isn’t an option, because it is Dr. Taylor’s name on the ED on-call roster today.

Each PCP creates a referral list for hospitalists to follow. New hospitalist practices often agree to follow the consulting patterns of each referring PCP. This can increase PCP acceptance of the HM model, and after all, the GI doctor consulted by the hospitalist during the few days in the hospital is the same one who will be working with the PCP when the patient has outpatient issues requiring GI specialty care. This usually means that the hospitalist carries a list of each PCP, and which GI doctor, orthopedist, etc., that particular PCP likes to consult. When the hospitalist needs an ortho consult, she first verifies the PCP this patient sees, then pulls out the list to see the orthopedist(s) that PCP prefers.

 

 

In most settings, either form of a mandated referral list is a poor system for hospitalists and is best avoided. Instead, the hospitalists should be free to deviate from the ED call list as they see fit. And while they should be attentive to the consulting preferences of each PCP, it is best not to promise the PCPs that their preference will always be followed. Providing the hospitalists this latitude means they can tailor the choice of consultant to the patient’s needs and the level of service (i.e. able, affable, available) each provides. And, at least in theory, when there are competing providers in a given specialty, they will have an incentive to provide better service to the hospitalist as a way of ensuring future referrals.

Practical Considerations

Even though I think it is optimal for hospitalists to have a lot of latitude in which doctors they consult, there are some practical considerations to keep in mind. For example, if the patient’s PCP is in a group that also has surgeons, it will be best to call one of them, and not a competing surgeon, when the patient has surgical needs. And the hospitalists as a group should usually make some effort to avoid never consulting a particular provider or group, as that could lead the “blackballed” doctor or group to complain enough that the medical staff or hospital leadership might force the hospitalists to follow the ED call roster when choosing referrals.

The number of physicians seeking hospital employment, which is steadily increasing these days, will in many settings increase sensitivities around referral patterns. For example, if your hospital has had three competing general surgery groups and one chooses to become hospital-employed, then the other two groups are likely to worry a lot that the hospitalists might be directed by the hospital to preferentially refer to the newly employed surgeons. Even if your hospitalist group has never had any sort of encouragement to do this, it could be very hard to convince the non-hospital-employed surgeons of this. This could become such a sensitive issue that it might be necessary to carefully track the number of referrals to each surgical group.

Join Team Hospitalist

Want to share your unique perspective on hot topics in HM? Team Hospitalist is accepting applications for two-year terms beginning in April. If you are interested in joining the team, e-mail Editor Jason Carris at [email protected].

And to prevent arguments like “You just consult us on the bad or uninsured patients,” you might also need to track the nature of the patient’s problem and insurance status, and whether the referral led to a procedure. The best approach will be to try to prevent these sorts of things from coming up by maintaining good communication and relations with other physician groups and thinking deliberately about your referral patterns. TH

Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program.” This column represents his views and is not intended to reflect an official position of SHM.

Issue
The Hospitalist - 2011(02)
Publications
Sections

I like to ask laypeople what they think “hospitalist” means. For years, I was confident that they had never heard the term, but now my question is more often met with an accurate response.

A hotel desk clerk in 1998 actually made one of the cleverest guesses I’ve ever heard. For the whole day, she and her colleagues had in front of them a sign that read “Hospitalist Meeting in the Ballroom,” which got them talking about what in the world a hospitalist is. Seeing from my badge that I was attending that meeting, she asked me what the term meant, but she first gamely provided her best guess: “Someone who makes lists of hospitals.”

There seems to be no end to the number of healthcare-related nouns and verbs to which someone attaches the suffix “ist.” Some days I request so many consults that I’m just a “referralist” (one who refers patients; surely this is a term we can do without). But don’t let the headline of this column confuse you: I really am addressing the lists used to determine which doctor to refer patients to.

When there are competing providers in a given specialty, they will have an incentive to provide better service to the hospitalist as a way of ensuring future referrals.

Hospitalist Referrals

The first of two common referral lists for hospitalists is a directory of primary-care physicians (PCPs) and clinics, as well as some other providers that refer patients to the hospitalist. Nearly all hospitalist groups maintain such a list, and they might apply a variety of terms such as “subscriber” (which refers to hospitalists) and “nonsubscriber” physicians.

Because most HM groups care for patients who come from all or nearly all of the PCPs in an area, it is often simpler to just create a short list of those providers who don’t refer to the hospitalists. In many hospitals, there are just four or five providers on that list. ED providers are the ones who most often access this list. When visiting other hospitals, I often see a paper copy of the list taped up at the provider workstations in the ED.

Consult Who?

The other, and much less common, type of referral list governs which doctors the hospitalists are to consult. There are two strategies that come up when thinking about this kind of list.

Do what the ED doctors do. ED physicians typically are constrained by the list of on-call physicians for each specialty, and are to always consult that doctor rather than another. For example, the ED doctor is required to consult Dr. Taylor for any patient in need of a general surgeon and doesn’t have a prior relationship with one. Tomorrow, the ED doctor is required to consult Dr. Simon. Dr. Taylor and Dr. Simon are to be contacted because they are the ones on call for the ED those days. Even if the ED doctor would rather consult Dr. Simon today (maybe she is more able, affable, and available than Dr. Taylor), that isn’t an option, because it is Dr. Taylor’s name on the ED on-call roster today.

Each PCP creates a referral list for hospitalists to follow. New hospitalist practices often agree to follow the consulting patterns of each referring PCP. This can increase PCP acceptance of the HM model, and after all, the GI doctor consulted by the hospitalist during the few days in the hospital is the same one who will be working with the PCP when the patient has outpatient issues requiring GI specialty care. This usually means that the hospitalist carries a list of each PCP, and which GI doctor, orthopedist, etc., that particular PCP likes to consult. When the hospitalist needs an ortho consult, she first verifies the PCP this patient sees, then pulls out the list to see the orthopedist(s) that PCP prefers.

 

 

In most settings, either form of a mandated referral list is a poor system for hospitalists and is best avoided. Instead, the hospitalists should be free to deviate from the ED call list as they see fit. And while they should be attentive to the consulting preferences of each PCP, it is best not to promise the PCPs that their preference will always be followed. Providing the hospitalists this latitude means they can tailor the choice of consultant to the patient’s needs and the level of service (i.e. able, affable, available) each provides. And, at least in theory, when there are competing providers in a given specialty, they will have an incentive to provide better service to the hospitalist as a way of ensuring future referrals.

Practical Considerations

Even though I think it is optimal for hospitalists to have a lot of latitude in which doctors they consult, there are some practical considerations to keep in mind. For example, if the patient’s PCP is in a group that also has surgeons, it will be best to call one of them, and not a competing surgeon, when the patient has surgical needs. And the hospitalists as a group should usually make some effort to avoid never consulting a particular provider or group, as that could lead the “blackballed” doctor or group to complain enough that the medical staff or hospital leadership might force the hospitalists to follow the ED call roster when choosing referrals.

The number of physicians seeking hospital employment, which is steadily increasing these days, will in many settings increase sensitivities around referral patterns. For example, if your hospital has had three competing general surgery groups and one chooses to become hospital-employed, then the other two groups are likely to worry a lot that the hospitalists might be directed by the hospital to preferentially refer to the newly employed surgeons. Even if your hospitalist group has never had any sort of encouragement to do this, it could be very hard to convince the non-hospital-employed surgeons of this. This could become such a sensitive issue that it might be necessary to carefully track the number of referrals to each surgical group.

Join Team Hospitalist

Want to share your unique perspective on hot topics in HM? Team Hospitalist is accepting applications for two-year terms beginning in April. If you are interested in joining the team, e-mail Editor Jason Carris at [email protected].

And to prevent arguments like “You just consult us on the bad or uninsured patients,” you might also need to track the nature of the patient’s problem and insurance status, and whether the referral led to a procedure. The best approach will be to try to prevent these sorts of things from coming up by maintaining good communication and relations with other physician groups and thinking deliberately about your referral patterns. TH

Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program.” This column represents his views and is not intended to reflect an official position of SHM.

I like to ask laypeople what they think “hospitalist” means. For years, I was confident that they had never heard the term, but now my question is more often met with an accurate response.

A hotel desk clerk in 1998 actually made one of the cleverest guesses I’ve ever heard. For the whole day, she and her colleagues had in front of them a sign that read “Hospitalist Meeting in the Ballroom,” which got them talking about what in the world a hospitalist is. Seeing from my badge that I was attending that meeting, she asked me what the term meant, but she first gamely provided her best guess: “Someone who makes lists of hospitals.”

There seems to be no end to the number of healthcare-related nouns and verbs to which someone attaches the suffix “ist.” Some days I request so many consults that I’m just a “referralist” (one who refers patients; surely this is a term we can do without). But don’t let the headline of this column confuse you: I really am addressing the lists used to determine which doctor to refer patients to.

When there are competing providers in a given specialty, they will have an incentive to provide better service to the hospitalist as a way of ensuring future referrals.

Hospitalist Referrals

The first of two common referral lists for hospitalists is a directory of primary-care physicians (PCPs) and clinics, as well as some other providers that refer patients to the hospitalist. Nearly all hospitalist groups maintain such a list, and they might apply a variety of terms such as “subscriber” (which refers to hospitalists) and “nonsubscriber” physicians.

Because most HM groups care for patients who come from all or nearly all of the PCPs in an area, it is often simpler to just create a short list of those providers who don’t refer to the hospitalists. In many hospitals, there are just four or five providers on that list. ED providers are the ones who most often access this list. When visiting other hospitals, I often see a paper copy of the list taped up at the provider workstations in the ED.

Consult Who?

The other, and much less common, type of referral list governs which doctors the hospitalists are to consult. There are two strategies that come up when thinking about this kind of list.

Do what the ED doctors do. ED physicians typically are constrained by the list of on-call physicians for each specialty, and are to always consult that doctor rather than another. For example, the ED doctor is required to consult Dr. Taylor for any patient in need of a general surgeon and doesn’t have a prior relationship with one. Tomorrow, the ED doctor is required to consult Dr. Simon. Dr. Taylor and Dr. Simon are to be contacted because they are the ones on call for the ED those days. Even if the ED doctor would rather consult Dr. Simon today (maybe she is more able, affable, and available than Dr. Taylor), that isn’t an option, because it is Dr. Taylor’s name on the ED on-call roster today.

Each PCP creates a referral list for hospitalists to follow. New hospitalist practices often agree to follow the consulting patterns of each referring PCP. This can increase PCP acceptance of the HM model, and after all, the GI doctor consulted by the hospitalist during the few days in the hospital is the same one who will be working with the PCP when the patient has outpatient issues requiring GI specialty care. This usually means that the hospitalist carries a list of each PCP, and which GI doctor, orthopedist, etc., that particular PCP likes to consult. When the hospitalist needs an ortho consult, she first verifies the PCP this patient sees, then pulls out the list to see the orthopedist(s) that PCP prefers.

 

 

In most settings, either form of a mandated referral list is a poor system for hospitalists and is best avoided. Instead, the hospitalists should be free to deviate from the ED call list as they see fit. And while they should be attentive to the consulting preferences of each PCP, it is best not to promise the PCPs that their preference will always be followed. Providing the hospitalists this latitude means they can tailor the choice of consultant to the patient’s needs and the level of service (i.e. able, affable, available) each provides. And, at least in theory, when there are competing providers in a given specialty, they will have an incentive to provide better service to the hospitalist as a way of ensuring future referrals.

Practical Considerations

Even though I think it is optimal for hospitalists to have a lot of latitude in which doctors they consult, there are some practical considerations to keep in mind. For example, if the patient’s PCP is in a group that also has surgeons, it will be best to call one of them, and not a competing surgeon, when the patient has surgical needs. And the hospitalists as a group should usually make some effort to avoid never consulting a particular provider or group, as that could lead the “blackballed” doctor or group to complain enough that the medical staff or hospital leadership might force the hospitalists to follow the ED call roster when choosing referrals.

The number of physicians seeking hospital employment, which is steadily increasing these days, will in many settings increase sensitivities around referral patterns. For example, if your hospital has had three competing general surgery groups and one chooses to become hospital-employed, then the other two groups are likely to worry a lot that the hospitalists might be directed by the hospital to preferentially refer to the newly employed surgeons. Even if your hospitalist group has never had any sort of encouragement to do this, it could be very hard to convince the non-hospital-employed surgeons of this. This could become such a sensitive issue that it might be necessary to carefully track the number of referrals to each surgical group.

Join Team Hospitalist

Want to share your unique perspective on hot topics in HM? Team Hospitalist is accepting applications for two-year terms beginning in April. If you are interested in joining the team, e-mail Editor Jason Carris at [email protected].

And to prevent arguments like “You just consult us on the bad or uninsured patients,” you might also need to track the nature of the patient’s problem and insurance status, and whether the referral led to a procedure. The best approach will be to try to prevent these sorts of things from coming up by maintaining good communication and relations with other physician groups and thinking deliberately about your referral patterns. TH

Dr. Nelson has been a practicing hospitalist since 1988 and is co-founder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program.” This column represents his views and is not intended to reflect an official position of SHM.

Issue
The Hospitalist - 2011(02)
Issue
The Hospitalist - 2011(02)
Publications
Publications
Article Type
Display Headline
Referral Lists
Display Headline
Referral Lists
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

When is endocervical curettage informative in cervical cancer screening?

Article Type
Changed
Display Headline
When is endocervical curettage informative in cervical cancer screening?

Although more than 400 studies have explored the use of ECC in cervical cancer screening, the practice remains controversial. Because this procedure most commonly involves circumferential scraping of the endocervical canal using a curette to obtain a specimen, the procedure can be painful, and some women may be reluctant afterward to continue follow-up. In addition, inadequate sampling is a frequent problem, making the specimen difficult or impossible to interpret. Furthermore, an ectocervical lesion that happens to get sampled inadvertently may contaminate the endocervical specimen, leading to potential diagnostic inaccuracy.

Despite these disadvantages, ECC remains fairly widely used. Proponents of ECC contend that ECC may be the only indicator of serious cervical lesions and, therefore, should be performed routinely. Alternatively, some colposcopists perform an ECC only when there is a specific indication, such as a high-grade squamous intraepithelial lesion (HSIL) on cervical cytology, or in the setting of an inadequate colposcopic examination.

Large data set is a strength

Gage and coworkers are authors of the latest ECC investigation, a data analysis from a regional health system in Canada that performs colposcopically guided biopsy and ECC on all outpatients undergoing colposcopy examination. A strength of their study is the large data set they used, which also allowed for analysis of subgroups to determine whether any subset of women may benefit from ECC. Indeed, the investigators did identify women who would be more likely to benefit from ECC: those 46 years or older who are referred for colposcopy after a high-grade cytology report. However, these same women are also likely to have an indication for an excisional procedure, obviating the need for ECC.

Gage and colleagues also reported the number needed to treat to identify one case of high-grade cytology that otherwise would have been missed: 99. This figure is a valuable aid in interpreting the significance of the results of this study as well as in counseling patients.

Keep the findings in context

Because the authors analyzed only cases in which both ECC and colposcopically directed biopsy were available for review, we cannot extrapolate these findings to cases in which only ECC is performed.

Also, keep in mind that use of a cyto-brush may boost sensitivity and adequacy of the specimen, in comparison with a curette, but may reduce specificity unless a sleeved brush is used. Gage and coworkers do not specify the technique utilized during ECC. They do remark on the pain associated with ECC, however, suggesting that the ECC procedures were performed using a curette.

Last, in regard to the difficulty encountered in the interpretation of some ECC specimens, it is important to recognize that, in contrast to reproducibility data available for cervical biopsy specimens, there is essentially no published reproducibility data on ECC specimens.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

This large study bolsters the “con” side of the ECC debate and is consistent with other investigations demonstrating minimal utility of the procedure. At this time, ECC is not recommended for routine use.

This study found that the diagnostic yield of ECC was lowest among women who had a fully visible transformation zone and who:

  • were younger than 46 years
  • used an oral contraceptive
  • were premenopausal
  • had fewer than 4 live births.

Diagnostic yield also was low among women of all ages who were referred for low-grade cytology.

ECC appears to have the greatest utility among women 46 years and older who are referred for high-grade CIN, HSIL, or more ominous cytologic findings and who have had four or more live births. However, many of these same women will also likely have an indication for an excisional procedure regardless of the ECC results, which may limit the utility of the procedure. —COL. CHRISTOPHER M. ZAHN, MD

We want to hear from you! Tell us what you think.

Article PDF
Author and Disclosure Information

RARELY. This analysis of data from Calgary Health Region colposcopy clinics found that, overall, endocervical curettage (ECC) is “rarely informative” when it is used routinely as an adjunct to colposcopy.

When ECC was performed at the time of 13,115 colposcopy examinations with guided biopsy, ECC increased the rate of diagnosis of cervical intraepithelial neoplasia (CIN) grade 2 or worse by 1.01%. It was necessary to perform 99 ECC procedures to identify one case of CIN 2+.

Gage JC, Duggan MA, Nation JG, Gao S, Castle PE. Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations. Am J Obstet Gynecol. 2010;203(5):481.e1–9.

EXPERT COMMENTARY

Col. Christopher M. Zahn, MD
Professor and Interim Chair, Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Bethesda, Md.

Issue
OBG Management - 23(02)
Publications
Topics
Page Number
18-19
Legacy Keywords
When is endocervical curettage informative in cervical Ca screening;Col. Christopher M. Zahn MD;Examining the Evidence;Calgary Health Region;colposcopy;endocervical curettage;ECC;guided biopsy;cervical intraepithelial neoplasia;CIN;cyto-brush;sleeved cyto-brush;pain;cervical biopsy specimens;premenopausal;oral contraceptive;low-grade cytology;high-grade cytology;high-grade squamous intraepithelial lesion;HSIL;cervical cancer screening
Sections
Author and Disclosure Information

RARELY. This analysis of data from Calgary Health Region colposcopy clinics found that, overall, endocervical curettage (ECC) is “rarely informative” when it is used routinely as an adjunct to colposcopy.

When ECC was performed at the time of 13,115 colposcopy examinations with guided biopsy, ECC increased the rate of diagnosis of cervical intraepithelial neoplasia (CIN) grade 2 or worse by 1.01%. It was necessary to perform 99 ECC procedures to identify one case of CIN 2+.

Gage JC, Duggan MA, Nation JG, Gao S, Castle PE. Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations. Am J Obstet Gynecol. 2010;203(5):481.e1–9.

EXPERT COMMENTARY

Col. Christopher M. Zahn, MD
Professor and Interim Chair, Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Bethesda, Md.

Author and Disclosure Information

RARELY. This analysis of data from Calgary Health Region colposcopy clinics found that, overall, endocervical curettage (ECC) is “rarely informative” when it is used routinely as an adjunct to colposcopy.

When ECC was performed at the time of 13,115 colposcopy examinations with guided biopsy, ECC increased the rate of diagnosis of cervical intraepithelial neoplasia (CIN) grade 2 or worse by 1.01%. It was necessary to perform 99 ECC procedures to identify one case of CIN 2+.

Gage JC, Duggan MA, Nation JG, Gao S, Castle PE. Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations. Am J Obstet Gynecol. 2010;203(5):481.e1–9.

EXPERT COMMENTARY

Col. Christopher M. Zahn, MD
Professor and Interim Chair, Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Bethesda, Md.

Article PDF
Article PDF

Although more than 400 studies have explored the use of ECC in cervical cancer screening, the practice remains controversial. Because this procedure most commonly involves circumferential scraping of the endocervical canal using a curette to obtain a specimen, the procedure can be painful, and some women may be reluctant afterward to continue follow-up. In addition, inadequate sampling is a frequent problem, making the specimen difficult or impossible to interpret. Furthermore, an ectocervical lesion that happens to get sampled inadvertently may contaminate the endocervical specimen, leading to potential diagnostic inaccuracy.

Despite these disadvantages, ECC remains fairly widely used. Proponents of ECC contend that ECC may be the only indicator of serious cervical lesions and, therefore, should be performed routinely. Alternatively, some colposcopists perform an ECC only when there is a specific indication, such as a high-grade squamous intraepithelial lesion (HSIL) on cervical cytology, or in the setting of an inadequate colposcopic examination.

Large data set is a strength

Gage and coworkers are authors of the latest ECC investigation, a data analysis from a regional health system in Canada that performs colposcopically guided biopsy and ECC on all outpatients undergoing colposcopy examination. A strength of their study is the large data set they used, which also allowed for analysis of subgroups to determine whether any subset of women may benefit from ECC. Indeed, the investigators did identify women who would be more likely to benefit from ECC: those 46 years or older who are referred for colposcopy after a high-grade cytology report. However, these same women are also likely to have an indication for an excisional procedure, obviating the need for ECC.

Gage and colleagues also reported the number needed to treat to identify one case of high-grade cytology that otherwise would have been missed: 99. This figure is a valuable aid in interpreting the significance of the results of this study as well as in counseling patients.

Keep the findings in context

Because the authors analyzed only cases in which both ECC and colposcopically directed biopsy were available for review, we cannot extrapolate these findings to cases in which only ECC is performed.

Also, keep in mind that use of a cyto-brush may boost sensitivity and adequacy of the specimen, in comparison with a curette, but may reduce specificity unless a sleeved brush is used. Gage and coworkers do not specify the technique utilized during ECC. They do remark on the pain associated with ECC, however, suggesting that the ECC procedures were performed using a curette.

Last, in regard to the difficulty encountered in the interpretation of some ECC specimens, it is important to recognize that, in contrast to reproducibility data available for cervical biopsy specimens, there is essentially no published reproducibility data on ECC specimens.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

This large study bolsters the “con” side of the ECC debate and is consistent with other investigations demonstrating minimal utility of the procedure. At this time, ECC is not recommended for routine use.

This study found that the diagnostic yield of ECC was lowest among women who had a fully visible transformation zone and who:

  • were younger than 46 years
  • used an oral contraceptive
  • were premenopausal
  • had fewer than 4 live births.

Diagnostic yield also was low among women of all ages who were referred for low-grade cytology.

ECC appears to have the greatest utility among women 46 years and older who are referred for high-grade CIN, HSIL, or more ominous cytologic findings and who have had four or more live births. However, many of these same women will also likely have an indication for an excisional procedure regardless of the ECC results, which may limit the utility of the procedure. —COL. CHRISTOPHER M. ZAHN, MD

We want to hear from you! Tell us what you think.

Although more than 400 studies have explored the use of ECC in cervical cancer screening, the practice remains controversial. Because this procedure most commonly involves circumferential scraping of the endocervical canal using a curette to obtain a specimen, the procedure can be painful, and some women may be reluctant afterward to continue follow-up. In addition, inadequate sampling is a frequent problem, making the specimen difficult or impossible to interpret. Furthermore, an ectocervical lesion that happens to get sampled inadvertently may contaminate the endocervical specimen, leading to potential diagnostic inaccuracy.

Despite these disadvantages, ECC remains fairly widely used. Proponents of ECC contend that ECC may be the only indicator of serious cervical lesions and, therefore, should be performed routinely. Alternatively, some colposcopists perform an ECC only when there is a specific indication, such as a high-grade squamous intraepithelial lesion (HSIL) on cervical cytology, or in the setting of an inadequate colposcopic examination.

Large data set is a strength

Gage and coworkers are authors of the latest ECC investigation, a data analysis from a regional health system in Canada that performs colposcopically guided biopsy and ECC on all outpatients undergoing colposcopy examination. A strength of their study is the large data set they used, which also allowed for analysis of subgroups to determine whether any subset of women may benefit from ECC. Indeed, the investigators did identify women who would be more likely to benefit from ECC: those 46 years or older who are referred for colposcopy after a high-grade cytology report. However, these same women are also likely to have an indication for an excisional procedure, obviating the need for ECC.

Gage and colleagues also reported the number needed to treat to identify one case of high-grade cytology that otherwise would have been missed: 99. This figure is a valuable aid in interpreting the significance of the results of this study as well as in counseling patients.

Keep the findings in context

Because the authors analyzed only cases in which both ECC and colposcopically directed biopsy were available for review, we cannot extrapolate these findings to cases in which only ECC is performed.

Also, keep in mind that use of a cyto-brush may boost sensitivity and adequacy of the specimen, in comparison with a curette, but may reduce specificity unless a sleeved brush is used. Gage and coworkers do not specify the technique utilized during ECC. They do remark on the pain associated with ECC, however, suggesting that the ECC procedures were performed using a curette.

Last, in regard to the difficulty encountered in the interpretation of some ECC specimens, it is important to recognize that, in contrast to reproducibility data available for cervical biopsy specimens, there is essentially no published reproducibility data on ECC specimens.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

This large study bolsters the “con” side of the ECC debate and is consistent with other investigations demonstrating minimal utility of the procedure. At this time, ECC is not recommended for routine use.

This study found that the diagnostic yield of ECC was lowest among women who had a fully visible transformation zone and who:

  • were younger than 46 years
  • used an oral contraceptive
  • were premenopausal
  • had fewer than 4 live births.

Diagnostic yield also was low among women of all ages who were referred for low-grade cytology.

ECC appears to have the greatest utility among women 46 years and older who are referred for high-grade CIN, HSIL, or more ominous cytologic findings and who have had four or more live births. However, many of these same women will also likely have an indication for an excisional procedure regardless of the ECC results, which may limit the utility of the procedure. —COL. CHRISTOPHER M. ZAHN, MD

We want to hear from you! Tell us what you think.

Issue
OBG Management - 23(02)
Issue
OBG Management - 23(02)
Page Number
18-19
Page Number
18-19
Publications
Publications
Topics
Article Type
Display Headline
When is endocervical curettage informative in cervical cancer screening?
Display Headline
When is endocervical curettage informative in cervical cancer screening?
Legacy Keywords
When is endocervical curettage informative in cervical Ca screening;Col. Christopher M. Zahn MD;Examining the Evidence;Calgary Health Region;colposcopy;endocervical curettage;ECC;guided biopsy;cervical intraepithelial neoplasia;CIN;cyto-brush;sleeved cyto-brush;pain;cervical biopsy specimens;premenopausal;oral contraceptive;low-grade cytology;high-grade cytology;high-grade squamous intraepithelial lesion;HSIL;cervical cancer screening
Legacy Keywords
When is endocervical curettage informative in cervical Ca screening;Col. Christopher M. Zahn MD;Examining the Evidence;Calgary Health Region;colposcopy;endocervical curettage;ECC;guided biopsy;cervical intraepithelial neoplasia;CIN;cyto-brush;sleeved cyto-brush;pain;cervical biopsy specimens;premenopausal;oral contraceptive;low-grade cytology;high-grade cytology;high-grade squamous intraepithelial lesion;HSIL;cervical cancer screening
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Does the rate of postcesarean maternal infection vary by uterine closure technique?

Article Type
Changed
Display Headline
Does the rate of postcesarean maternal infection vary by uterine closure technique?

More than one million cesarean deliveries are performed each year in the United States. That’s more than two cesarean deliveries every minute. Clearly, performing this most common of major surgeries safely and effectively is of the utmost importance.

The much-anticipated CAESAR study is a large randomized, controlled trial that assesses three technical aspects of cesarean delivery:

  • single-layer versus double-layer uterine closure. The investigators define the former as approximation of both edges of the uterine incision using a single layer of sutures. Double-layer closure involves one set of sutures at the endometrial layer and an additional set of sutures at the serosal layer
  • closure versus nonclosure of the pelvic peritoneum
  • liberal versus restricted use of a subrectus sheath drain.

The primary outcome of this study is maternal infectious morbidity. Women who participated in the trial were all undergoing their first cesarean delivery, which was performed through the lower uterine segment. In addition, none of the women had a clear indication for any of the techniques explored in this study.

As in any trial, the findings of the CAESAR study should be interpreted in view of the totality of the literature. Other aspects of cesarean delivery have been summarized previously. 1

In the short term, the type of uterine closure doesn’t seem to matter

In the CAESAR trial, single-layer closure of the uterine incision was not associated with any effect on maternal infectious morbidity, compared with double-layer closure. In earlier randomized, controlled trials, single-layer closure was associated with shorter operative time, less blood loss, and less pain. 2

An important issue is the long-term effect of single-layer uterine closure, especially the incidence of uterine rupture in subsequent trials of labor, compared with double-layer closure. The CAESAR study did not report this outcome, but we hope that it will in the future, as it is one of the largest trials to explore uterine closure.

Closure of the peritoneum

In earlier randomized, controlled trials, non-closure of the pelvic peritoneum has been associated with shorter operative time and hospitalization, a lower rate of fever, and less need for analgesia. 3

In the CAESAR trial, nonclosure of the peritoneum was not associated with any effect on maternal infectious morbidity, compared with closure.

Use of a drain is best limited

In the CAESAR trial, restricted use of a subrectus sheath drain was not associated with any effect on maternal infectious morbidity, compared with liberal use. In earlier trials, drainage was not associated with any bene-fit. 4 Therefore, it seems preferable to limit use of these drains during cesarean delivery.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

It is too soon for us to know the long-term effects of these cesarean delivery techniques, but neither single-layer nor double-layer uterine closure appears to affect the rate of maternal postoperative infection.

Nonclosure of the peritoneum is preferred to closure, based on Level I literature on this issue.

Liberal use of a subrectus sheath drain is of little benefit. Its use should be limited. —VINCENZO BERGHELLA, MD

We want to hear from you! Tell us what you think.

References

1. Berghella V, Baxter JK, Chauhan SP. Evidence-based surgery for cesarean delivery. Am J Obstet Gynecol. 2005;193(5):1607-1617.

2. Dodd JM, Anderson ER, Gates S. Surgical techniques for uterine incision and uterine closure at the time of caesarean section. Cochrane Database Syst Rev. 2008;(3):CD004732.-

3. Bamigboye AA, Hofmeyr JG. Closure versus non-closure of the peritoneum at caesarean section. Cochrane Database Syst Rev. 1998;(1):CD000163.-doi: 10.1002/14651858. CD000163.

4. Gates S, Anderson ER. Wound drainage for caesarean section. Cochrane Database Syst Rev. 2005;(1):CD004549.-doi: 10.1002/14651858.CD004549.pub2.

Article PDF
Author and Disclosure Information

NO. According to findings from the CAESAR Study, a randomized trial of more than 3,000 women, the rate of maternal infectious morbidity was the same regardless of whether uterine closure was single-layer or double-layer.

The rates of maternal infection also were similar for closure versus nonclosure of the peritoneum and for liberal versus restricted use of a subrectus sheath drain.

CAESAR Study Collaborative Group. Cesarean section surgical techniques: a randomized factorial trial. BJOG. 2010;117(11):1366-1376.

EXPERT COMMENTARY

Vincenzo Berghella, MD
Professor of Obstetrics and Gynecology; Director of the Division of Maternal-Fetal Medicine; and Director of the Maternal-Fetal Medicine Fellowship Program, Thomas Jefferson University, Jefferson Medical College, Philadelphia.

Issue
OBG Management - 23(02)
Publications
Topics
Page Number
56-57
Legacy Keywords
postcesarean maternal infection;uterine closure technique;Examining the Evidence;Vincenzo Berghella MD;maternal infection;nonclosure of peritoneum;single-layer closure;double-layer closure;subrectus sheath drain;CAESAR study collaborative group;uterine closure;uterine rupture;nonclosure;analgesia;cesarea delivery techniques;approximation of both edges of the uterine incision;uterine incision;endometrial layer;serosal layer;pelvic peritoneum;subrectus sheath drain;lower uterine segment;
Sections
Author and Disclosure Information

NO. According to findings from the CAESAR Study, a randomized trial of more than 3,000 women, the rate of maternal infectious morbidity was the same regardless of whether uterine closure was single-layer or double-layer.

The rates of maternal infection also were similar for closure versus nonclosure of the peritoneum and for liberal versus restricted use of a subrectus sheath drain.

CAESAR Study Collaborative Group. Cesarean section surgical techniques: a randomized factorial trial. BJOG. 2010;117(11):1366-1376.

EXPERT COMMENTARY

Vincenzo Berghella, MD
Professor of Obstetrics and Gynecology; Director of the Division of Maternal-Fetal Medicine; and Director of the Maternal-Fetal Medicine Fellowship Program, Thomas Jefferson University, Jefferson Medical College, Philadelphia.

Author and Disclosure Information

NO. According to findings from the CAESAR Study, a randomized trial of more than 3,000 women, the rate of maternal infectious morbidity was the same regardless of whether uterine closure was single-layer or double-layer.

The rates of maternal infection also were similar for closure versus nonclosure of the peritoneum and for liberal versus restricted use of a subrectus sheath drain.

CAESAR Study Collaborative Group. Cesarean section surgical techniques: a randomized factorial trial. BJOG. 2010;117(11):1366-1376.

EXPERT COMMENTARY

Vincenzo Berghella, MD
Professor of Obstetrics and Gynecology; Director of the Division of Maternal-Fetal Medicine; and Director of the Maternal-Fetal Medicine Fellowship Program, Thomas Jefferson University, Jefferson Medical College, Philadelphia.

Article PDF
Article PDF

More than one million cesarean deliveries are performed each year in the United States. That’s more than two cesarean deliveries every minute. Clearly, performing this most common of major surgeries safely and effectively is of the utmost importance.

The much-anticipated CAESAR study is a large randomized, controlled trial that assesses three technical aspects of cesarean delivery:

  • single-layer versus double-layer uterine closure. The investigators define the former as approximation of both edges of the uterine incision using a single layer of sutures. Double-layer closure involves one set of sutures at the endometrial layer and an additional set of sutures at the serosal layer
  • closure versus nonclosure of the pelvic peritoneum
  • liberal versus restricted use of a subrectus sheath drain.

The primary outcome of this study is maternal infectious morbidity. Women who participated in the trial were all undergoing their first cesarean delivery, which was performed through the lower uterine segment. In addition, none of the women had a clear indication for any of the techniques explored in this study.

As in any trial, the findings of the CAESAR study should be interpreted in view of the totality of the literature. Other aspects of cesarean delivery have been summarized previously. 1

In the short term, the type of uterine closure doesn’t seem to matter

In the CAESAR trial, single-layer closure of the uterine incision was not associated with any effect on maternal infectious morbidity, compared with double-layer closure. In earlier randomized, controlled trials, single-layer closure was associated with shorter operative time, less blood loss, and less pain. 2

An important issue is the long-term effect of single-layer uterine closure, especially the incidence of uterine rupture in subsequent trials of labor, compared with double-layer closure. The CAESAR study did not report this outcome, but we hope that it will in the future, as it is one of the largest trials to explore uterine closure.

Closure of the peritoneum

In earlier randomized, controlled trials, non-closure of the pelvic peritoneum has been associated with shorter operative time and hospitalization, a lower rate of fever, and less need for analgesia. 3

In the CAESAR trial, nonclosure of the peritoneum was not associated with any effect on maternal infectious morbidity, compared with closure.

Use of a drain is best limited

In the CAESAR trial, restricted use of a subrectus sheath drain was not associated with any effect on maternal infectious morbidity, compared with liberal use. In earlier trials, drainage was not associated with any bene-fit. 4 Therefore, it seems preferable to limit use of these drains during cesarean delivery.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

It is too soon for us to know the long-term effects of these cesarean delivery techniques, but neither single-layer nor double-layer uterine closure appears to affect the rate of maternal postoperative infection.

Nonclosure of the peritoneum is preferred to closure, based on Level I literature on this issue.

Liberal use of a subrectus sheath drain is of little benefit. Its use should be limited. —VINCENZO BERGHELLA, MD

We want to hear from you! Tell us what you think.

More than one million cesarean deliveries are performed each year in the United States. That’s more than two cesarean deliveries every minute. Clearly, performing this most common of major surgeries safely and effectively is of the utmost importance.

The much-anticipated CAESAR study is a large randomized, controlled trial that assesses three technical aspects of cesarean delivery:

  • single-layer versus double-layer uterine closure. The investigators define the former as approximation of both edges of the uterine incision using a single layer of sutures. Double-layer closure involves one set of sutures at the endometrial layer and an additional set of sutures at the serosal layer
  • closure versus nonclosure of the pelvic peritoneum
  • liberal versus restricted use of a subrectus sheath drain.

The primary outcome of this study is maternal infectious morbidity. Women who participated in the trial were all undergoing their first cesarean delivery, which was performed through the lower uterine segment. In addition, none of the women had a clear indication for any of the techniques explored in this study.

As in any trial, the findings of the CAESAR study should be interpreted in view of the totality of the literature. Other aspects of cesarean delivery have been summarized previously. 1

In the short term, the type of uterine closure doesn’t seem to matter

In the CAESAR trial, single-layer closure of the uterine incision was not associated with any effect on maternal infectious morbidity, compared with double-layer closure. In earlier randomized, controlled trials, single-layer closure was associated with shorter operative time, less blood loss, and less pain. 2

An important issue is the long-term effect of single-layer uterine closure, especially the incidence of uterine rupture in subsequent trials of labor, compared with double-layer closure. The CAESAR study did not report this outcome, but we hope that it will in the future, as it is one of the largest trials to explore uterine closure.

Closure of the peritoneum

In earlier randomized, controlled trials, non-closure of the pelvic peritoneum has been associated with shorter operative time and hospitalization, a lower rate of fever, and less need for analgesia. 3

In the CAESAR trial, nonclosure of the peritoneum was not associated with any effect on maternal infectious morbidity, compared with closure.

Use of a drain is best limited

In the CAESAR trial, restricted use of a subrectus sheath drain was not associated with any effect on maternal infectious morbidity, compared with liberal use. In earlier trials, drainage was not associated with any bene-fit. 4 Therefore, it seems preferable to limit use of these drains during cesarean delivery.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

It is too soon for us to know the long-term effects of these cesarean delivery techniques, but neither single-layer nor double-layer uterine closure appears to affect the rate of maternal postoperative infection.

Nonclosure of the peritoneum is preferred to closure, based on Level I literature on this issue.

Liberal use of a subrectus sheath drain is of little benefit. Its use should be limited. —VINCENZO BERGHELLA, MD

We want to hear from you! Tell us what you think.

References

1. Berghella V, Baxter JK, Chauhan SP. Evidence-based surgery for cesarean delivery. Am J Obstet Gynecol. 2005;193(5):1607-1617.

2. Dodd JM, Anderson ER, Gates S. Surgical techniques for uterine incision and uterine closure at the time of caesarean section. Cochrane Database Syst Rev. 2008;(3):CD004732.-

3. Bamigboye AA, Hofmeyr JG. Closure versus non-closure of the peritoneum at caesarean section. Cochrane Database Syst Rev. 1998;(1):CD000163.-doi: 10.1002/14651858. CD000163.

4. Gates S, Anderson ER. Wound drainage for caesarean section. Cochrane Database Syst Rev. 2005;(1):CD004549.-doi: 10.1002/14651858.CD004549.pub2.

References

1. Berghella V, Baxter JK, Chauhan SP. Evidence-based surgery for cesarean delivery. Am J Obstet Gynecol. 2005;193(5):1607-1617.

2. Dodd JM, Anderson ER, Gates S. Surgical techniques for uterine incision and uterine closure at the time of caesarean section. Cochrane Database Syst Rev. 2008;(3):CD004732.-

3. Bamigboye AA, Hofmeyr JG. Closure versus non-closure of the peritoneum at caesarean section. Cochrane Database Syst Rev. 1998;(1):CD000163.-doi: 10.1002/14651858. CD000163.

4. Gates S, Anderson ER. Wound drainage for caesarean section. Cochrane Database Syst Rev. 2005;(1):CD004549.-doi: 10.1002/14651858.CD004549.pub2.

Issue
OBG Management - 23(02)
Issue
OBG Management - 23(02)
Page Number
56-57
Page Number
56-57
Publications
Publications
Topics
Article Type
Display Headline
Does the rate of postcesarean maternal infection vary by uterine closure technique?
Display Headline
Does the rate of postcesarean maternal infection vary by uterine closure technique?
Legacy Keywords
postcesarean maternal infection;uterine closure technique;Examining the Evidence;Vincenzo Berghella MD;maternal infection;nonclosure of peritoneum;single-layer closure;double-layer closure;subrectus sheath drain;CAESAR study collaborative group;uterine closure;uterine rupture;nonclosure;analgesia;cesarea delivery techniques;approximation of both edges of the uterine incision;uterine incision;endometrial layer;serosal layer;pelvic peritoneum;subrectus sheath drain;lower uterine segment;
Legacy Keywords
postcesarean maternal infection;uterine closure technique;Examining the Evidence;Vincenzo Berghella MD;maternal infection;nonclosure of peritoneum;single-layer closure;double-layer closure;subrectus sheath drain;CAESAR study collaborative group;uterine closure;uterine rupture;nonclosure;analgesia;cesarea delivery techniques;approximation of both edges of the uterine incision;uterine incision;endometrial layer;serosal layer;pelvic peritoneum;subrectus sheath drain;lower uterine segment;
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Health IT Hurdles

Article Type
Changed
Display Headline
Health IT Hurdles

I rent cars regularly, and only occasionally do I get the same model twice. I’m ready to roll after spending a couple of minutes becoming familiar with a car that is new to me. I adjust the seat and climate control, etc. I resist fiddling with the radio until later. This seems OK to me.

The last time I started clinical practice in a new hospital, I did almost the same thing: I jumped right in and started seeing patients. Other than being provided with my password to the computer system and a dictation code, I had no orientation at all, not even to the hospital floor plan. This, too, seemed reasonable to me at the time. Now I see it differently.

I worry that it will be increasingly difficult, and potentially unwise, for a doctor in any specialty to practice at more than one or two hospitals that don’t share the same electronic health record system.

Levels of Complexity

Years ago, learning a new hospital might not have been a lot more difficult than familiarizing yourself with a new rental car, so there didn’t seem to be much need for a detailed orientation. I’m generalizing here, but if you go back far enough in time, the general idea was that it was almost entirely up to the hospital and its staff to get to know the new doctor and how he or she practiced, rather than the doctor adapting to the hospital’s way of doing things.

While at one time hospitals and their systems might have been as similar to one another as a four-door Chevy is to a four-door Ford, today’s hospitals are far more complex. The appropriate transportation analogy might be one type of airplane to another.

The basics of what keeps a two-seat Cessna and a huge 747 flying are the same, but there are so many critical differences that specific training and certification are required for each. Even an accomplished professional pilot who is an ace in a 747 isn’t automatically certified to pilot a smaller 737. In fact, few professional pilots are certified to fly more than one type of commercial airplane at a time. One way to look at this is that the orientation to the plane is so complex that one person can’t be expected to maintain a high level of familiarity with the systems and operation of more than one at a time.

EHR: A Tipping Point

The complexity and unique attributes of hospitals have been increasing steadily for decades, but it seems to me that electronic health records (EHR) represent a huge increase in complexity. No longer can a doctor simply arrive at the hospital confident in her ability to fly this new plane. She will require a reasonably detailed introduction to the hospital’s EHR as part of an orientation that should ideally take place prior to seeing patients.

I worry that it will be increasingly difficult, and potentially unwise, for a doctor in any specialty to practice at more than one or two hospitals that don’t share the same EHR. If a doctor is not proficient in the use of the EHR at a particular site, two things are likely to happen: First, and most alarmingly, the new doctor would probably unintentionally miss important information in the EHR, or might not have time to contemplate the series of buttons to click to check all potentially relevant information. For example, he might not realize the patient already had a series of blood tests, because accessing them requires some unfamiliar clicks of the mouse.

 

 

The other thing that might happen if a doctor is not proficient in the use of the hospital’s EHR is that he might be inclined to consult the hospitalist “just to cover all the bases.” In this case, that might be the same as asking the hospitalist to be involved as an EHR expert, rather than for medical expertise that the patient needs.

I practice at a hospital that recently installed a new information system, and some doctors have joked that if they can’t figure out how to use it, they will just consult a hospitalist to look up historical data, etc. I’m not aware of any study looking at this issue, but I suspect “soft” hospitalist consults increase when a hospital installs a new information system.

Rethink New Employee Orientation

I’m convinced that new doctors in all specialties that anticipate having a hospital patient volume above a predetermined threshold should be required to have a formal orientation to the hospital, especially for its information system. This is really important for hospitalists. Every practice should think carefully about a meaningful process of orientation to the hospital and the hospitalist practice itself. The latter would include things like scheduling issues, training in CPT coding, group governance and culture, etc.

My experience is that multistate hospitalist companies have pretty detailed orientation programs; for one thing, they can use this as a differentiator when marketing their services. But private hospitalist practices and groups employed by a single hospital usually have a pretty loose orientation process. It is tricky to find the sweet spot between valuable orientation activities and so much detail that the new doctor is overwhelmed or bored, and unlikely to remember much of what is presented.

And there certainly is a role for waiting to learn some things as the new doctor begins seeing patients. For example, my feeling is that a general orientation to the floor plan is sufficient and the new hire can best learn the details independently during the course of patient care. However, all hospitalists should have some reasonable level of proficiency in the EHR before seeing their first patients.

Hospital-Certified?

If you accept my premise that hospitals were once reasonably similar, like one rental car to another, but have now become as complex and different as jumbo jets, then we’re led to another question: Will we one day decide that a doctor must be certified to practice in a particular hospital by demonstrating knowledge and competence in that particular hospital’s systems and procedures?

Nearly all present-day credentialing and privileging related to a doctor’s work in a hospital focus on that doctor’s prior training and experience. In the case of pilots, there is a requirement to demonstrate proficiency when making a transition to a new airplane.

Maybe an analogous system of certification for a doctor to “fly” each hospital would be valuable for our patients. If training might not make sense for all doctors, then perhaps limit it to those, such as hospitalists, who will have a really high patient volume at the facility.

It would be dizzyingly complex to create and referee such a certification system, so I’m not sure anything like this will happen in my career. And the last thing I want is another set of bureaucratic hurdles.

But it might be worth thinking about how to ensure doctors at a particular hospital are expert enough in that hospital’s unique systems and operations. Start with your group’s orientation process. TH

 

 

Dr. Nelson has been a practicing hospitalist since 1988 and is cofounder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is also course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program” course. This column represents his views and is not intended to reflect an official position of SHM.

Issue
The Hospitalist - 2011(01)
Publications
Sections

I rent cars regularly, and only occasionally do I get the same model twice. I’m ready to roll after spending a couple of minutes becoming familiar with a car that is new to me. I adjust the seat and climate control, etc. I resist fiddling with the radio until later. This seems OK to me.

The last time I started clinical practice in a new hospital, I did almost the same thing: I jumped right in and started seeing patients. Other than being provided with my password to the computer system and a dictation code, I had no orientation at all, not even to the hospital floor plan. This, too, seemed reasonable to me at the time. Now I see it differently.

I worry that it will be increasingly difficult, and potentially unwise, for a doctor in any specialty to practice at more than one or two hospitals that don’t share the same electronic health record system.

Levels of Complexity

Years ago, learning a new hospital might not have been a lot more difficult than familiarizing yourself with a new rental car, so there didn’t seem to be much need for a detailed orientation. I’m generalizing here, but if you go back far enough in time, the general idea was that it was almost entirely up to the hospital and its staff to get to know the new doctor and how he or she practiced, rather than the doctor adapting to the hospital’s way of doing things.

While at one time hospitals and their systems might have been as similar to one another as a four-door Chevy is to a four-door Ford, today’s hospitals are far more complex. The appropriate transportation analogy might be one type of airplane to another.

The basics of what keeps a two-seat Cessna and a huge 747 flying are the same, but there are so many critical differences that specific training and certification are required for each. Even an accomplished professional pilot who is an ace in a 747 isn’t automatically certified to pilot a smaller 737. In fact, few professional pilots are certified to fly more than one type of commercial airplane at a time. One way to look at this is that the orientation to the plane is so complex that one person can’t be expected to maintain a high level of familiarity with the systems and operation of more than one at a time.

EHR: A Tipping Point

The complexity and unique attributes of hospitals have been increasing steadily for decades, but it seems to me that electronic health records (EHR) represent a huge increase in complexity. No longer can a doctor simply arrive at the hospital confident in her ability to fly this new plane. She will require a reasonably detailed introduction to the hospital’s EHR as part of an orientation that should ideally take place prior to seeing patients.

I worry that it will be increasingly difficult, and potentially unwise, for a doctor in any specialty to practice at more than one or two hospitals that don’t share the same EHR. If a doctor is not proficient in the use of the EHR at a particular site, two things are likely to happen: First, and most alarmingly, the new doctor would probably unintentionally miss important information in the EHR, or might not have time to contemplate the series of buttons to click to check all potentially relevant information. For example, he might not realize the patient already had a series of blood tests, because accessing them requires some unfamiliar clicks of the mouse.

 

 

The other thing that might happen if a doctor is not proficient in the use of the hospital’s EHR is that he might be inclined to consult the hospitalist “just to cover all the bases.” In this case, that might be the same as asking the hospitalist to be involved as an EHR expert, rather than for medical expertise that the patient needs.

I practice at a hospital that recently installed a new information system, and some doctors have joked that if they can’t figure out how to use it, they will just consult a hospitalist to look up historical data, etc. I’m not aware of any study looking at this issue, but I suspect “soft” hospitalist consults increase when a hospital installs a new information system.

Rethink New Employee Orientation

I’m convinced that new doctors in all specialties that anticipate having a hospital patient volume above a predetermined threshold should be required to have a formal orientation to the hospital, especially for its information system. This is really important for hospitalists. Every practice should think carefully about a meaningful process of orientation to the hospital and the hospitalist practice itself. The latter would include things like scheduling issues, training in CPT coding, group governance and culture, etc.

My experience is that multistate hospitalist companies have pretty detailed orientation programs; for one thing, they can use this as a differentiator when marketing their services. But private hospitalist practices and groups employed by a single hospital usually have a pretty loose orientation process. It is tricky to find the sweet spot between valuable orientation activities and so much detail that the new doctor is overwhelmed or bored, and unlikely to remember much of what is presented.

And there certainly is a role for waiting to learn some things as the new doctor begins seeing patients. For example, my feeling is that a general orientation to the floor plan is sufficient and the new hire can best learn the details independently during the course of patient care. However, all hospitalists should have some reasonable level of proficiency in the EHR before seeing their first patients.

Hospital-Certified?

If you accept my premise that hospitals were once reasonably similar, like one rental car to another, but have now become as complex and different as jumbo jets, then we’re led to another question: Will we one day decide that a doctor must be certified to practice in a particular hospital by demonstrating knowledge and competence in that particular hospital’s systems and procedures?

Nearly all present-day credentialing and privileging related to a doctor’s work in a hospital focus on that doctor’s prior training and experience. In the case of pilots, there is a requirement to demonstrate proficiency when making a transition to a new airplane.

Maybe an analogous system of certification for a doctor to “fly” each hospital would be valuable for our patients. If training might not make sense for all doctors, then perhaps limit it to those, such as hospitalists, who will have a really high patient volume at the facility.

It would be dizzyingly complex to create and referee such a certification system, so I’m not sure anything like this will happen in my career. And the last thing I want is another set of bureaucratic hurdles.

But it might be worth thinking about how to ensure doctors at a particular hospital are expert enough in that hospital’s unique systems and operations. Start with your group’s orientation process. TH

 

 

Dr. Nelson has been a practicing hospitalist since 1988 and is cofounder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is also course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program” course. This column represents his views and is not intended to reflect an official position of SHM.

I rent cars regularly, and only occasionally do I get the same model twice. I’m ready to roll after spending a couple of minutes becoming familiar with a car that is new to me. I adjust the seat and climate control, etc. I resist fiddling with the radio until later. This seems OK to me.

The last time I started clinical practice in a new hospital, I did almost the same thing: I jumped right in and started seeing patients. Other than being provided with my password to the computer system and a dictation code, I had no orientation at all, not even to the hospital floor plan. This, too, seemed reasonable to me at the time. Now I see it differently.

I worry that it will be increasingly difficult, and potentially unwise, for a doctor in any specialty to practice at more than one or two hospitals that don’t share the same electronic health record system.

Levels of Complexity

Years ago, learning a new hospital might not have been a lot more difficult than familiarizing yourself with a new rental car, so there didn’t seem to be much need for a detailed orientation. I’m generalizing here, but if you go back far enough in time, the general idea was that it was almost entirely up to the hospital and its staff to get to know the new doctor and how he or she practiced, rather than the doctor adapting to the hospital’s way of doing things.

While at one time hospitals and their systems might have been as similar to one another as a four-door Chevy is to a four-door Ford, today’s hospitals are far more complex. The appropriate transportation analogy might be one type of airplane to another.

The basics of what keeps a two-seat Cessna and a huge 747 flying are the same, but there are so many critical differences that specific training and certification are required for each. Even an accomplished professional pilot who is an ace in a 747 isn’t automatically certified to pilot a smaller 737. In fact, few professional pilots are certified to fly more than one type of commercial airplane at a time. One way to look at this is that the orientation to the plane is so complex that one person can’t be expected to maintain a high level of familiarity with the systems and operation of more than one at a time.

EHR: A Tipping Point

The complexity and unique attributes of hospitals have been increasing steadily for decades, but it seems to me that electronic health records (EHR) represent a huge increase in complexity. No longer can a doctor simply arrive at the hospital confident in her ability to fly this new plane. She will require a reasonably detailed introduction to the hospital’s EHR as part of an orientation that should ideally take place prior to seeing patients.

I worry that it will be increasingly difficult, and potentially unwise, for a doctor in any specialty to practice at more than one or two hospitals that don’t share the same EHR. If a doctor is not proficient in the use of the EHR at a particular site, two things are likely to happen: First, and most alarmingly, the new doctor would probably unintentionally miss important information in the EHR, or might not have time to contemplate the series of buttons to click to check all potentially relevant information. For example, he might not realize the patient already had a series of blood tests, because accessing them requires some unfamiliar clicks of the mouse.

 

 

The other thing that might happen if a doctor is not proficient in the use of the hospital’s EHR is that he might be inclined to consult the hospitalist “just to cover all the bases.” In this case, that might be the same as asking the hospitalist to be involved as an EHR expert, rather than for medical expertise that the patient needs.

I practice at a hospital that recently installed a new information system, and some doctors have joked that if they can’t figure out how to use it, they will just consult a hospitalist to look up historical data, etc. I’m not aware of any study looking at this issue, but I suspect “soft” hospitalist consults increase when a hospital installs a new information system.

Rethink New Employee Orientation

I’m convinced that new doctors in all specialties that anticipate having a hospital patient volume above a predetermined threshold should be required to have a formal orientation to the hospital, especially for its information system. This is really important for hospitalists. Every practice should think carefully about a meaningful process of orientation to the hospital and the hospitalist practice itself. The latter would include things like scheduling issues, training in CPT coding, group governance and culture, etc.

My experience is that multistate hospitalist companies have pretty detailed orientation programs; for one thing, they can use this as a differentiator when marketing their services. But private hospitalist practices and groups employed by a single hospital usually have a pretty loose orientation process. It is tricky to find the sweet spot between valuable orientation activities and so much detail that the new doctor is overwhelmed or bored, and unlikely to remember much of what is presented.

And there certainly is a role for waiting to learn some things as the new doctor begins seeing patients. For example, my feeling is that a general orientation to the floor plan is sufficient and the new hire can best learn the details independently during the course of patient care. However, all hospitalists should have some reasonable level of proficiency in the EHR before seeing their first patients.

Hospital-Certified?

If you accept my premise that hospitals were once reasonably similar, like one rental car to another, but have now become as complex and different as jumbo jets, then we’re led to another question: Will we one day decide that a doctor must be certified to practice in a particular hospital by demonstrating knowledge and competence in that particular hospital’s systems and procedures?

Nearly all present-day credentialing and privileging related to a doctor’s work in a hospital focus on that doctor’s prior training and experience. In the case of pilots, there is a requirement to demonstrate proficiency when making a transition to a new airplane.

Maybe an analogous system of certification for a doctor to “fly” each hospital would be valuable for our patients. If training might not make sense for all doctors, then perhaps limit it to those, such as hospitalists, who will have a really high patient volume at the facility.

It would be dizzyingly complex to create and referee such a certification system, so I’m not sure anything like this will happen in my career. And the last thing I want is another set of bureaucratic hurdles.

But it might be worth thinking about how to ensure doctors at a particular hospital are expert enough in that hospital’s unique systems and operations. Start with your group’s orientation process. TH

 

 

Dr. Nelson has been a practicing hospitalist since 1988 and is cofounder and past president of SHM. He is a principal in Nelson Flores Hospital Medicine Consultants, a national hospitalist practice management consulting firm (www.nelsonflores.com). He is also course co-director and faculty for SHM’s “Best Practices in Managing a Hospital Medicine Program” course. This column represents his views and is not intended to reflect an official position of SHM.

Issue
The Hospitalist - 2011(01)
Issue
The Hospitalist - 2011(01)
Publications
Publications
Article Type
Display Headline
Health IT Hurdles
Display Headline
Health IT Hurdles
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)